<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32102377</article-id>
<article-id pub-id-type="pmc">7073220</article-id>
<article-id pub-id-type="doi">10.3390/ijms21041538</article-id>
<article-id pub-id-type="publisher-id">ijms-21-01538</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Franchini</surname>
<given-names>Luca</given-names>
</name>
<xref ref-type="author-notes" rid="fn1-ijms-21-01538">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carrano</surname>
<given-names>Nicolò</given-names>
</name>
<xref ref-type="author-notes" rid="fn1-ijms-21-01538">†</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2298-615X</contrib-id>
<name>
<surname>Di Luca</surname>
<given-names>Monica</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gardoni</surname>
<given-names>Fabrizio</given-names>
</name>
<xref ref-type="corresp" rid="c1-ijms-21-01538">*</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-21-01538">Department of Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy; <email>luca.franchini@unimi.it</email> (L.F.); <email>nicolo.carrano@unimi.it</email> (N.C.); <email>monica.diluca@unimi.it</email> (M.D.L.)</aff>
<author-notes>
<corresp id="c1-ijms-21-01538"><label>*</label>Correspondence: <email>fabrizio.gardoni@unimi.it</email>; Tel.: +39-0250318374/314</corresp>
<fn id="fn1-ijms-21-01538">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>2</month>
<year>2020</year>
</pub-date>
<volume>21</volume>
<issue>4</issue>
<elocation-id>1538</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>1</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>2</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 by the authors.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>N-Methyl-<sc>d</sc>-Aspartate Receptors (NMDARs) are ionotropic glutamate-gated receptors. NMDARs are tetramers composed by several homologous subunits of GluN1-, GluN2-, or GluN3-type, leading to the existence in the central nervous system of a high variety of receptor subtypes with different pharmacological and signaling properties. NMDAR subunit composition is strictly regulated during development and by activity-dependent synaptic plasticity. Given the differences between GluN2 regulatory subunits of NMDAR in several functions, here we will focus on the synaptic pool of NMDARs containing the GluN2A subunit, addressing its role in both physiology and pathological synaptic plasticity as well as the contribution in these events of different types of GluN2A-interacting proteins. </p>
</abstract>
<kwd-group>
<kwd>Glutamate</kwd>
<kwd>NMDA receptors</kwd>
<kwd>dendritic spines</kwd>
<kwd>synaptic plasticity</kwd>
<kwd>brain disorders</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-21-01538" sec-type="intro">
<title>1. Introduction</title>
<p>N-Methyl-<sc>d</sc>-Aspartate Receptors (NMDARs) are ligand- and voltage-gated ionotropic glutamate receptors (iGluRs) promoting Ca<sup>2+</sup> and Na<sup>+</sup> influx. In particular, the NMDAR pore channel is blocked by Mg<sup>2+</sup> at resting potential and this event is removed by an adequate depolarization. Therefore, in the canonical view, activation of NMDARs represents a coincidence detector of presynaptic glutamate release and postsynaptic depolarization [<xref ref-type="bibr" rid="B1-ijms-21-01538">1</xref>,<xref ref-type="bibr" rid="B2-ijms-21-01538">2</xref>]. This view requires NMDARs be located postsynaptically [<xref ref-type="bibr" rid="B3-ijms-21-01538">3</xref>]. Nonetheless, the presence of NMDARs in the presynapse has long been described in several brain areas, like cortex [<xref ref-type="bibr" rid="B4-ijms-21-01538">4</xref>,<xref ref-type="bibr" rid="B5-ijms-21-01538">5</xref>], hippocampus [<xref ref-type="bibr" rid="B6-ijms-21-01538">6</xref>,<xref ref-type="bibr" rid="B7-ijms-21-01538">7</xref>], and cerebellum [<xref ref-type="bibr" rid="B8-ijms-21-01538">8</xref>,<xref ref-type="bibr" rid="B9-ijms-21-01538">9</xref>], and also in the spinal cord [<xref ref-type="bibr" rid="B10-ijms-21-01538">10</xref>]. Moreover, in parallel with the classic view of ion influx as the only NMDAR signaling, several studies pointed out a NMDAR metabotropic cascade independently of ion-flow. In particular, the NMDAR metabotropic activity results from a complex intracellular “signalosome”, which is mostly involved in synaptic receptor endocytosis and trafficking [<xref ref-type="bibr" rid="B11-ijms-21-01538">11</xref>,<xref ref-type="bibr" rid="B12-ijms-21-01538">12</xref>,<xref ref-type="bibr" rid="B13-ijms-21-01538">13</xref>,<xref ref-type="bibr" rid="B14-ijms-21-01538">14</xref>], and depression of neurotransmission such as NMDAR-dependent Long-Term Depression (LTD) [<xref ref-type="bibr" rid="B15-ijms-21-01538">15</xref>,<xref ref-type="bibr" rid="B16-ijms-21-01538">16</xref>,<xref ref-type="bibr" rid="B17-ijms-21-01538">17</xref>,<xref ref-type="bibr" rid="B18-ijms-21-01538">18</xref>,<xref ref-type="bibr" rid="B19-ijms-21-01538">19</xref>]. </p>
<p>NMDARs are tetramers composed by two obligatory GluN1 subunits, associated with two regulatory subunits of GluN2-type and GluN3-type, expressed in several different isoforms (GluN2A-D and GluN3A-B) at different brain regions and at different developmental periods. According to the neurodevelopmental switch theory, GluN2B/GluN2D and GluN3A/GluN3B are more abundant in early developmental stages, whereas GluN2A/GluN2C are more expressed in mature ones [<xref ref-type="bibr" rid="B20-ijms-21-01538">20</xref>,<xref ref-type="bibr" rid="B21-ijms-21-01538">21</xref>]. </p>
<p>GluN2A and GluN2B are by far the most abundant NMDAR regulatory subunits expressed in the mammalian brain [<xref ref-type="bibr" rid="B20-ijms-21-01538">20</xref>,<xref ref-type="bibr" rid="B21-ijms-21-01538">21</xref>,<xref ref-type="bibr" rid="B22-ijms-21-01538">22</xref>]. GluN2A-containing NMDARs are highly expressed in the adult hippocampus and neocortex while in other brain areas such as the striatum the GluN2B-containing NMDARs are predominant. Notably, GluN2A-containing NMDARs are more localized at synaptic sites and enriched in the postsynaptic density (PSD) compared to extrasynaptic sites [<xref ref-type="bibr" rid="B22-ijms-21-01538">22</xref>,<xref ref-type="bibr" rid="B23-ijms-21-01538">23</xref>,<xref ref-type="bibr" rid="B24-ijms-21-01538">24</xref>] and display a slower mobility compared to other GluN2-containing ones [<xref ref-type="bibr" rid="B25-ijms-21-01538">25</xref>]. </p>
<p>GluN2A confers unique channel properties to NMDARs containing this subunit, starting from high sensitivity to Mg<sup>2+</sup> [<xref ref-type="bibr" rid="B26-ijms-21-01538">26</xref>]. Chen et al. reported that GluN2A-containing NMDAR mediate large currents, as suggested by the peak current densities [<xref ref-type="bibr" rid="B27-ijms-21-01538">27</xref>]. Moreover, this subunit grants the NMDAR a high channel open probability [<xref ref-type="bibr" rid="B27-ijms-21-01538">27</xref>]. In postnatal cortical neurons, regardless their age, the presence of GluN2A mRNA was associated to faster NMDAR EPSC compared to negative cells [<xref ref-type="bibr" rid="B28-ijms-21-01538">28</xref>]. GluN2 subunits are also the main regulators of the open/close state of the NMDAR. In this context, GluN2A-containing receptors have a reversible calcium-dependent inactivation, whereas other kinds of NMDARs, like the GluN2B-containing ones, do not significantly suffer for calcium-dependent inactivation [<xref ref-type="bibr" rid="B29-ijms-21-01538">29</xref>]. Another important feature owned by GluN2A-containing NMDARs is the fast recovery from desensitization [<xref ref-type="bibr" rid="B30-ijms-21-01538">30</xref>]. To summarize, GluN2A confers to NMDAR specific electrophysiological properties, like high channel opening probability and conductance, more predisposed to desensitize but with a faster recovery, making these receptors versatile modulators of synaptic activity. </p>
<p>Synaptic NMDARs mainly mediate pro-survival and synaptic plasticity pathways, whereas extrasynaptic NMDARs are mostly responsible for glutamate excitotoxicity and are detrimental for neuronal functions [<xref ref-type="bibr" rid="B23-ijms-21-01538">23</xref>,<xref ref-type="bibr" rid="B31-ijms-21-01538">31</xref>]. Furthermore, the balance in synaptic GluN2-type subunits is responsible for adequate glutamatergic neurotransmission, which is altered in several neurological disorders and which is linked to the pathophysiology of brain diseases [<xref ref-type="bibr" rid="B22-ijms-21-01538">22</xref>,<xref ref-type="bibr" rid="B32-ijms-21-01538">32</xref>,<xref ref-type="bibr" rid="B33-ijms-21-01538">33</xref>]. Therefore, understanding the molecular mechanisms regulating NMDAR subunit composition at synapses, such as membrane insertion, and assembly and removal of specific regulatory subunits, represents a pharmacological challenge for the setting up of new therapeutic strategies for neurological disorders where NMDARs play a pivotal role [<xref ref-type="bibr" rid="B34-ijms-21-01538">34</xref>,<xref ref-type="bibr" rid="B35-ijms-21-01538">35</xref>]. In this review, we will focus on synaptic GluN2A-containing NMDARs, their role in synaptic plasticity and their contribution to pathological plasticity as observed in several brain disorders. </p>
</sec>
<sec id="sec2-ijms-21-01538">
<title>2. NMDAR Structure: Focus on the GluN2A Subunit</title>
<p>All NMDAR subunits contain an extracellular N-terminal domain (NTD), a transmembrane domain (TD), and an intracellular C-terminal domain (CTD). Within NTDs are located the agonist binding site (ABD) for glutamate (on GluN2 subunits) and glycine (on GluN1 and GluN3 subunits) [<xref ref-type="bibr" rid="B36-ijms-21-01538">36</xref>]. Zn<sup>2+</sup> ions are able to inhibit NMDAR currents probably by interacting with pore channel amino acids [<xref ref-type="bibr" rid="B37-ijms-21-01538">37</xref>,<xref ref-type="bibr" rid="B38-ijms-21-01538">38</xref>]; however, Zn<sup>2+</sup> can also inhibit specifically GluN2A-containing NMDARs due to an interaction site located on GluN2A NTD. In particular, Zn<sup>2+</sup> can relate allosterically with four residues (H42, H128, K233, and E266) [<xref ref-type="bibr" rid="B39-ijms-21-01538">39</xref>] belonging to GluN2A NTD, therefore providing inhibition and reducing NMDAR currents [<xref ref-type="bibr" rid="B40-ijms-21-01538">40</xref>,<xref ref-type="bibr" rid="B41-ijms-21-01538">41</xref>,<xref ref-type="bibr" rid="B42-ijms-21-01538">42</xref>,<xref ref-type="bibr" rid="B43-ijms-21-01538">43</xref>]. GluN2A NTD is also responsible for receptor structural changes in a closed conformation due to extracellular protonation (i.e., pH variations), which were shown to be independent of plasma membrane potential [<xref ref-type="bibr" rid="B44-ijms-21-01538">44</xref>,<xref ref-type="bibr" rid="B45-ijms-21-01538">45</xref>,<xref ref-type="bibr" rid="B46-ijms-21-01538">46</xref>] and agonist binding [<xref ref-type="bibr" rid="B47-ijms-21-01538">47</xref>]. This event was shown to be synergistically promoted by other NMDAR inhibitors, such as Zn<sup>2+</sup> [<xref ref-type="bibr" rid="B48-ijms-21-01538">48</xref>]. Recently, R370W and P79R mutations of the <italic>GRIN2A</italic> (Glutamate Ionotropic Receptor NMDA Type Subunit 2A) gene, encoding for the GluN2A subunit, have been associated with augmented and reduced sensitivity to Zn<sup>2+</sup>, respectively [<xref ref-type="bibr" rid="B49-ijms-21-01538">49</xref>]. Finally, the NTD of the GluN2A subunit shows an endoplasmic reticulum (ER) retention signal, which is absent on GluN2B homolog [<xref ref-type="bibr" rid="B50-ijms-21-01538">50</xref>] probably accounting for different delivery mechanisms to the synapse. </p>
<p>The TD displays an M2 loop involved in pore channel formation and responsible for Mg<sup>2+</sup> interaction. In particular, two asparagine residues from M2 loops belonging to the GluN2 and the GluN1 subunits are responsible of the Mg<sup>2+</sup> blockade [<xref ref-type="bibr" rid="B51-ijms-21-01538">51</xref>]. The <italic>C1845A</italic> mutation on <italic>GRIN2A</italic> gene encodes for GluN2AN651K variant at the M2 loop leading to low Mg<sup>2+</sup> blockade [<xref ref-type="bibr" rid="B51-ijms-21-01538">51</xref>], decrease in Ca<sup>2+</sup> permeability both for di-heteromeric and tri-heteromeric NMDARs, and to epileptic encephalopathy with cognitive impairment [<xref ref-type="bibr" rid="B52-ijms-21-01538">52</xref>,<xref ref-type="bibr" rid="B53-ijms-21-01538">53</xref>]. </p>
<p>The long CTD of GluN2 subunits displays the lowest homology among GluN2 isoforms, as well as various length and binding partners [<xref ref-type="bibr" rid="B25-ijms-21-01538">25</xref>,<xref ref-type="bibr" rid="B32-ijms-21-01538">32</xref>,<xref ref-type="bibr" rid="B54-ijms-21-01538">54</xref>]. GluN2 CTDs are necessary for receptor surface dynamics and activation of specific metabotropic signaling [<xref ref-type="bibr" rid="B32-ijms-21-01538">32</xref>,<xref ref-type="bibr" rid="B55-ijms-21-01538">55</xref>]. Protein–protein interactions at the GluN2A CTD are involved in the lower mobility of GluN2A-containing NMDARs at synapses compared to GluN2B-containing ones [<xref ref-type="bibr" rid="B25-ijms-21-01538">25</xref>] (see below) [<xref ref-type="bibr" rid="B55-ijms-21-01538">55</xref>]. GluN2 CTD as well as NTD were reported to affect receptor trafficking from the ER, indicating a complex modulation of the receptor delivery to target regions [<xref ref-type="bibr" rid="B56-ijms-21-01538">56</xref>]. </p>
<p>NMDAR can be modulated through subunit phosphorylation of different residues at the CTD, which represent also a well-demonstrated fast mechanism for activation or maintenance of synaptic plasticity events [<xref ref-type="bibr" rid="B57-ijms-21-01538">57</xref>]. In particular, CTD phosphorylation is important for the endocytosis/removal of NMDARs, which occurs during synaptic plasticity events [<xref ref-type="bibr" rid="B58-ijms-21-01538">58</xref>] and agonist binding [<xref ref-type="bibr" rid="B11-ijms-21-01538">11</xref>,<xref ref-type="bibr" rid="B12-ijms-21-01538">12</xref>,<xref ref-type="bibr" rid="B13-ijms-21-01538">13</xref>,<xref ref-type="bibr" rid="B59-ijms-21-01538">59</xref>]. Vissel and collaborators (2001) reported a use-dependent dephosphorylation of NMDAR associated with low amplitude recordings given by augmented endocytosis of the receptors mediated by AP2 and dynamin [<xref ref-type="bibr" rid="B11-ijms-21-01538">11</xref>]. This event was dependent on agonist concentrations and time interval of treatments. Furthermore, they identified the GluN2A CTD portions responsible for the endocytosis, such as Tyr842 which is well known to interact with a consensus motif (µ2) on AP2, and additional residues between the 874-1464 fragment [<xref ref-type="bibr" rid="B11-ijms-21-01538">11</xref>].</p>
<p>Selective GluN2 antagonists represent pharmacological tools to investigate GluN2 subunits role both in physiological and pathological conditions. As for the GluN2A subunit, the mostly used selective antagonist is NVP-AAM077, which interacts with ABD of GluN2A and Glu781 on GluN1 subunit [<xref ref-type="bibr" rid="B60-ijms-21-01538">60</xref>]. The selectivity of NVP-AAM077 for GluN2A over GluN2B is, however, only approximately fivefold, suggesting a tight range of concentrations to be used [<xref ref-type="bibr" rid="B61-ijms-21-01538">61</xref>]. This probably explains why the variability of the results obtained with NVP-AAM077 in different experimental systems, thus suggesting that this compound should be used cautiously to investigate GluN2A contribution to neuronal functions.</p>
<p>Researchers recently developed new promising compounds with different pharmacological profile, such as GluN2A Negative Allosteric Modulators (NAMs) and Positive Allosteric Modulators (PAMs). As for GluN2A-NAMs, the most studied is TCN-201, which interacts with the ABD lower portion called S2 of GluN2A and GluN1; in particular, Leu780 and Val783 on GluN2A, whereas Arg755 on GluN1 [<xref ref-type="bibr" rid="B62-ijms-21-01538">62</xref>,<xref ref-type="bibr" rid="B63-ijms-21-01538">63</xref>,<xref ref-type="bibr" rid="B64-ijms-21-01538">64</xref>]. As for GluN2A-PAMs, scientists are making efforts in obtaining clean molecular profiles due to a PAM binding site shared between NMDARs and AMPA receptors (AMPARs) [<xref ref-type="bibr" rid="B54-ijms-21-01538">54</xref>]. Among PAMs, GNE-0723 was the first to be identified with a high potency and brain penetrance but poor pharmacokinetic profile [<xref ref-type="bibr" rid="B65-ijms-21-01538">65</xref>,<xref ref-type="bibr" rid="B66-ijms-21-01538">66</xref>]. After modification of GNE-0723 structure into GNE-5729, almost fivefold increased selectivity against AMPAR was achieved, maintaining good GluN2A potency and specificity [<xref ref-type="bibr" rid="B66-ijms-21-01538">66</xref>]. Overall, even if several advances have been performed in the last decade trying to identify novel compounds that are able to modulate selectively the GluN2A-containing NMDARs, additional work is needed to reach this goal.</p>
</sec>
<sec id="sec3-ijms-21-01538">
<title>3. GluN2A Subunit: Binding Partners</title>
<p>The GluN2A CTD binds a variety of synaptic proteins with different cellular functions. These protein–protein interactions play a pivotal role in the modulation of numerous properties of GluN2A-containing NMDARs, ranging from the regulation of downstream intracellular signaling to mechanisms involved in the synaptic retention of the receptor.</p>
<p>The GluN2A CTD domains responsible for the interaction with these partners sometimes overlap thus leading to the competition of different types of proteins for the interaction with the GluN2A subunit (see below). Importantly, it is known that some of these interactions depend on the activation state of the synapse. In particular, interactions at the GluN2A CTD are very often not static but dynamically regulated by synaptic activity and plasticity (<xref ref-type="fig" rid="ijms-21-01538-f001">Figure 1</xref>). Accordingly, different pools of GluN2A-containing NMDAR can be associated to different signalosome. Moreover, several protein–protein interactions described below have been shown to play a key role for Long-Term Potentiation (LTP) induction. Therefore, the knowledge of the interactors at the GluN2A-CTD and their binding mechanisms represent a helpful tool in understanding how GluN2A-containing NMDAR function is regulated.</p>
<p>Among GluN2A CTD interacting partners there are (1) scaffolding proteins, (2) synapse-to-nucleus messengers, (3) protein kinases, and (4) other proteins (see <xref ref-type="fig" rid="ijms-21-01538-f001">Figure 1</xref>). </p>
<sec id="sec3dot1-ijms-21-01538">
<title>3.1. Scaffolding Proteins</title>
<p>Several types of scaffolding proteins bind the distal domain of GluN2A CTD and these interactions mainly regulate GluN2A stability at synapses. Members of membrane-associated guanylate kinase (MAGUK) from the Discs Large subfamily (Dlg) such as PSD-95, PSD-93, SAP102, and SAP97 bind to the last three aa (1461–1464) of the GluN2A subunit and are responsible for GluN2A-containing NMDARs retention in PSD [<xref ref-type="bibr" rid="B67-ijms-21-01538">67</xref>,<xref ref-type="bibr" rid="B68-ijms-21-01538">68</xref>,<xref ref-type="bibr" rid="B69-ijms-21-01538">69</xref>,<xref ref-type="bibr" rid="B70-ijms-21-01538">70</xref>]. Similarly, the rab-effector protein Rabphilin3A (Rph3A) binds to GluN2A1349-1389 domain at synapses and promotes stabilization of GluN2A-containing NMDARs at the PSD, also thanks to the formation of a triple complex with PSD-95. Interestingly, the formation of this protein complex is triggered by LTP and disruption of Rph3A/GluN2A interaction through cell permeable peptides or Rph3A shRNA rapidly reduces synaptic levels of GluN2A-containing NMDARs and prevents LTP induction [<xref ref-type="bibr" rid="B71-ijms-21-01538">71</xref>]. FRMPD2, a scaffolding protein typically present in polarized cells and neurons, was found to interact selectively with GluN2A subunit of NMDARs through its PDZ2. Again, this association is necessary for receptor stabilization in PSD and its disruption leads to reduced GluN2A synaptic levels in CA1 region of hippocampus [<xref ref-type="bibr" rid="B72-ijms-21-01538">72</xref>]. Scribble1, a scaffolding protein involved in neural tube closure and presynaptic architecture was also described as a GluN2A binding partner at 1458–1464 domain promoting insertion at the PSD of GluN2A-containing NMDARs via interplay with AP2 [<xref ref-type="bibr" rid="B73-ijms-21-01538">73</xref>].</p>
</sec>
<sec id="sec3dot2-ijms-21-01538">
<title>3.2. Synapse-to-Nucleus Messengers </title>
<p>Long-distance NMDAR signaling to the nucleus contributes to activity-dependent regulation of gene expression that feeds back to synaptic function in health and disease. In addition to calcium signals, which represent a major route for communication of NMDAR activity to the nucleus, synaptonuclear protein messengers connect synapses and nucleus enabling bidirectional transfer of information. In particular, several synaptonuclear messengers are associated to NMDAR complex at the glutamatergic postsynaptic compartment and play a key role in the modulation of the LTP [<xref ref-type="bibr" rid="B74-ijms-21-01538">74</xref>,<xref ref-type="bibr" rid="B75-ijms-21-01538">75</xref>]. Ring Finger protein 10 (RNF10) binds the 991–1049 fragment of GluN2A subunit and migrates to the nucleus through the transporter importin-α after induction of LTP or synaptic NMDAR activation [<xref ref-type="bibr" rid="B76-ijms-21-01538">76</xref>].</p>
<p>AIDA-1d was shown to be present in the PSD during resting conditions, and to migrate to the nucleus upon NMDAR activation where it regulates protein synthesis and nucleoli number [<xref ref-type="bibr" rid="B77-ijms-21-01538">77</xref>]. An interaction site on GluN2 CTD has not been reported yet for AIDA-1d and it shows to preferentially colocalize and coimmunoprecipitate with GluN2B subunits over GluN2A, suggesting a promiscuous synapse-to-nucleus messenger. However, we cannot exclude AIDA-1d as potentially part of GluN2A-containing NMDAR signaling components. Nevertheless, it seems to mainly affect GluN2B-containing NMDARs assembly and trafficking to the synapse from the endoplasmic reticulum [<xref ref-type="bibr" rid="B77-ijms-21-01538">77</xref>].</p>
<p>Extracellular regulated kinase (ERK) is involved in Mitogen-Activated Protein Kinase (MAPK) downstream signaling and a synapse-to-nucleus communication, which still needs to be clarified. Both GluN2A- and GluN2B-containing NMDAR can be found upstream of ERK activation, suggesting ERK as a promiscuous signaling mediator [<xref ref-type="bibr" rid="B55-ijms-21-01538">55</xref>]. ERK was shown to be activated by only a subset of dendritic spines modulating CREB and Elk-1 activity [<xref ref-type="bibr" rid="B78-ijms-21-01538">78</xref>]. However, there is no direct demonstration of ERK translocation to the nucleus as well as no direct interaction reported yet on GluN2 CTDs. </p>
</sec>
<sec id="sec3dot3-ijms-21-01538">
<title>3.3. Protein Kinases</title>
<p>Several protein kinases play a relevant role at GluN2A-containing NMDAR complexes not only phosphorylating the GluN2A subunit, but also forming protein–protein interactions. Ca<sup>2+</sup>/calmodulin-dependent protein Kinase II (CaMKII) interacts with 1389–1464 domain of GluN2A [<xref ref-type="bibr" rid="B79-ijms-21-01538">79</xref>,<xref ref-type="bibr" rid="B80-ijms-21-01538">80</xref>] and with different CTD portions of GluN2B subunit (839–1120/1120–1489) depending on the kinase phosphorylation state [<xref ref-type="bibr" rid="B81-ijms-21-01538">81</xref>,<xref ref-type="bibr" rid="B82-ijms-21-01538">82</xref>]. CaMKII is the most abundant protein at the glutamatergic PSD and is activated by Ca<sup>2+</sup>-Calmodulin complexes driven by NMDAR opening. When this occurs, CaMKII autophosphorylates its autoinhibitory domain in T286, becoming active. The active conformation of CaMKII remains, even when the Ca<sup>2+</sup> stimulus has subsided, therefore it is also named as “molecular memory” [<xref ref-type="bibr" rid="B83-ijms-21-01538">83</xref>,<xref ref-type="bibr" rid="B84-ijms-21-01538">84</xref>,<xref ref-type="bibr" rid="B85-ijms-21-01538">85</xref>]. The interaction between GluN2A and this kinase was shown to be in an unphosphorylated state, but it is promoted by autophosphorylation of CaMKII [<xref ref-type="bibr" rid="B86-ijms-21-01538">86</xref>]. Increased formation of GluN2A/CaMKII complex induces also a disruption of GluN2A/PSD-95 interaction thus leading to a dynamic modification of GluN2A-interacting proteins following NMDAR activation [<xref ref-type="bibr" rid="B79-ijms-21-01538">79</xref>]. </p>
<p>Cyclin-Dependent Kinase 5 (CdK5) binds GluN2A at fragment 1218–1246, regulating receptor recycle and degradation via coordination with the protein AP2 [<xref ref-type="bibr" rid="B87-ijms-21-01538">87</xref>,<xref ref-type="bibr" rid="B88-ijms-21-01538">88</xref>]. Of relevance, Cdk5-dependent phosphorylation at Ser1232 seems to be important for LTP maintenance in CA1 region of hippocampus [<xref ref-type="bibr" rid="B88-ijms-21-01538">88</xref>].</p>
<p>Phospatidyl-inositol-3 kinase (PI3K) was reported to bind GluN2A- or GluN2B-containing NMDAR by interacting with GluN1 CTD. Activation of GluN2A containing NMDAR was shown to trigger PI3K signaling [<xref ref-type="bibr" rid="B89-ijms-21-01538">89</xref>,<xref ref-type="bibr" rid="B90-ijms-21-01538">90</xref>].</p>
</sec>
<sec id="sec3dot4-ijms-21-01538">
<title>3.4. Other Proteins</title>
<p>Guanine nucleotide exchange factors (GEFs): Brefeldin A-resistant Arf guanine nucleotide exchange factor 2 (BRAG2) binds 1078–1117 fragment of GluN2A CTD and mediates exchange of GDP to GTP at ADP-rybosilation factors (Arf) [<xref ref-type="bibr" rid="B91-ijms-21-01538">91</xref>]. However, also BRAG1 is able to interact with synaptic GluN2A-containing NMDAR complex, as reported previously by Sakagami [<xref ref-type="bibr" rid="B92-ijms-21-01538">92</xref>].</p>
<p>Ras-guanine nucleotide-releasing factor 2 (Ras-GRF2) is a Ca<sup>2+</sup>/Calmodulin (CaM) sensor mediating GluN2A-containing NMDAR signaling in mature neurons [<xref ref-type="bibr" rid="B93-ijms-21-01538">93</xref>], in fact its expression is developmentally regulated [<xref ref-type="bibr" rid="B94-ijms-21-01538">94</xref>]. In particular, Ras-GRF2 displays a GEF domain, a C-terminal cell division cycle 25 (CDC25) domain for Ras/ERK activation [<xref ref-type="bibr" rid="B95-ijms-21-01538">95</xref>,<xref ref-type="bibr" rid="B96-ijms-21-01538">96</xref>], and an N-terminal dbl homology (DH) domain activating Rac/p38 pathway [<xref ref-type="bibr" rid="B97-ijms-21-01538">97</xref>,<xref ref-type="bibr" rid="B98-ijms-21-01538">98</xref>]. Ras-GEF are important mediators of NMDARs late phase signaling, since they involve MAP kinases, ERK1/2 and also CREB phosphorylation which is important for gene expression [<xref ref-type="bibr" rid="B94-ijms-21-01538">94</xref>]. However, the domain of interaction between Ras-GRF2 and GluN2A has not been investigated.</p>
<p>IQGAP1 serves as a scaffold protein for different signaling pathways involving B-Raf, Rac1, Lis1, Cdc42, ERK, and MEK. IQGAP1 was found to preferentially interact with GluN2A-PSD-95 complexes compared to GluN2B-containing ones, thus indicating a possible signaling interplay through IQGAP1 between different pools of NMDAR [<xref ref-type="bibr" rid="B99-ijms-21-01538">99</xref>,<xref ref-type="bibr" rid="B100-ijms-21-01538">100</xref>,<xref ref-type="bibr" rid="B101-ijms-21-01538">101</xref>,<xref ref-type="bibr" rid="B102-ijms-21-01538">102</xref>].</p>
<p>Calmodulin (CaM) interacts with CTD of GluN2A subunit in a calcium-dependent manner at the 875-1029 domain, through interaction with a tryptophan residue (1014), which is critical for protein–protein interaction [<xref ref-type="bibr" rid="B103-ijms-21-01538">103</xref>]. Ca<sup>2+</sup>/Calmodulin complexes can be also considered as a synapse-to-nucleus messengers of the γCaMKII and γCaMKI signaling, regulating gene expression and cognitive functions [<xref ref-type="bibr" rid="B104-ijms-21-01538">104</xref>,<xref ref-type="bibr" rid="B105-ijms-21-01538">105</xref>,<xref ref-type="bibr" rid="B106-ijms-21-01538">106</xref>].</p>
<p>Bip, a recently discovered ER chaperone protein, is involved in the selective delivery of GluN2A-containing NMDAR at the synapse from the dendritic ER [<xref ref-type="bibr" rid="B107-ijms-21-01538">107</xref>]. </p>
</sec>
</sec>
<sec id="sec4-ijms-21-01538">
<title>4. GluN2A Subunit and Synaptic Plasticity</title>
<p>The influence of the NMDAR subunit composition on synaptic plasticity has been subject of a vast number of studies, trying to explain the unsolved question on how different patterns of neuronal stimulation lead to opposite modulation of synaptic strength acting on the same type of receptor. It is commonly accepted that the different levels of calcium influx associated with different degrees of NMDAR activation polarize the direction of plasticity towards LTP or LTD, as they couple to different intracellular signaling pathways. However, it was proposed that distinct subpopulations of NMDARs could exert a finer level of regulation on synaptic potentiation or depression triggered by different activity patterns. In this regard, GluN2A subunit has been intensively studied, as GluN2A-containing NMDAR has particular channel properties that generate distinct calcium dynamics in the postsynapse. Moreover, as described above, GluN2A CTD allows unique intracellular molecular associations with proteins like kinases and phosphatases and synaptonuclear messengers that intrinsically direct the plasticity signaling [<xref ref-type="bibr" rid="B33-ijms-21-01538">33</xref>,<xref ref-type="bibr" rid="B75-ijms-21-01538">75</xref>,<xref ref-type="bibr" rid="B108-ijms-21-01538">108</xref>]. Recently it was also reported a specific metabotropic function of GluN2A-containing NMDAR in mediating glycine-induced potentiation of AMPAR currents through the activation ERK1/2 signaling [<xref ref-type="bibr" rid="B109-ijms-21-01538">109</xref>]. The synaptic abundance and motility of this subunit affects the basal state of the spine and provides another level of control on the possibility to induce synaptic strengthening or weakening. In particular, the CA3-CA1 synapse of the hippocampal neurocircuitry represents the most commonly used model for the study of the putative role of different GluN2 subunits in synaptic plasticity. Pharmacological and genetic manipulations, or the combination of the two approaches, have been used in combination with several plasticity protocols. </p>
<sec id="sec4dot1-ijms-21-01538">
<title>4.1. Role of GluN2A in LTP</title>
<p>In 2004, a couple of seminal ex vivo studies showed that the selective pharmacological inhibition of GluN2A by NVP-AAM077 blocks tetanus- and pairing-induced LTP in three- to four-week rat hippocampal neurons [<xref ref-type="bibr" rid="B110-ijms-21-01538">110</xref>] and HFS-induced LTP in layer II and III cortical neurons [<xref ref-type="bibr" rid="B111-ijms-21-01538">111</xref>], but not LTD. A few years later the findings were confirmed on hippocampal neurons using the same antagonist and age of rats [<xref ref-type="bibr" rid="B112-ijms-21-01538">112</xref>] and also in two-week-old mice [<xref ref-type="bibr" rid="B113-ijms-21-01538">113</xref>]. In vivo pharmacological studies also showed that both intrahippocampal infusion and intraperitoneal injection of NVP-AAM077 was able to abolish LTP induction [<xref ref-type="bibr" rid="B114-ijms-21-01538">114</xref>]. The data in these studies seem to point out that GluN2A is a necessary element for LTP. However, the NVP-AAM077 concentration used in the aforementioned studies is relatively high and, as NVP-AAM077 affinity is just 5 times higher to GluN2A than GluN2B, it cannot be excluded that the block of LTP seen is uniquely GluN2A dependent. Moreover, this elevated concentration of NVP-AAM077 was able to induce a drastic reduction of the total NMDAR-mediated currents [<xref ref-type="bibr" rid="B110-ijms-21-01538">110</xref>,<xref ref-type="bibr" rid="B112-ijms-21-01538">112</xref>] that might have prevented the calcium influx necessary for LTP induction. Given that, the block of LTP induction seemed more likely to have arisen from a threshold effect on the total NMDAR-mediated currents than on the selective inhibition of GluN2A. In support of this theory, the group of Köhr found that in mice treated with a concentration of the antagonist that was titrated not to cause an excessive NMDAR-current reduction, pairing-induced LTP was not impaired [<xref ref-type="bibr" rid="B115-ijms-21-01538">115</xref>]. In another study, the same low NVP-AAM077 concentration also did not abolish LTP induction by a theta burst protocol [<xref ref-type="bibr" rid="B116-ijms-21-01538">116</xref>], but partially impaired tetanus-induced LTP [<xref ref-type="bibr" rid="B117-ijms-21-01538">117</xref>]. Overall, pharmacological studies did not clarify the role of the GluN2A subunits in LTP, even if the data of these studies suggest that GluN2A might have a more relevant function in tetanus-induced LTP, since it resulted the most sensitive to NVP-AAM077 treatment.</p>
<p>Several lines of evidence from a genetic manipulation approach further supported the idea of an involvement of GluN2A in LTP, as in both mice with reduced synaptic GluN2A [<xref ref-type="bibr" rid="B118-ijms-21-01538">118</xref>] or no GluN2A [<xref ref-type="bibr" rid="B119-ijms-21-01538">119</xref>], LTP is altered, but can be restored though a multiple tetanic induction protocol [<xref ref-type="bibr" rid="B120-ijms-21-01538">120</xref>]. A possible explanation for this functional recovery is that a stronger neuronal stimulation can restore the calcium influx that is usually supplied by GluN2A-containing NMDAR in high-frequency stimulation conditions. However, other studies put forward the idea that also GluN2A-interaction with molecular partners is important for synaptic strengthening. It has been shown that form of LTP dependent on the Ras-GRF2/Erk Map Kinase pathway can be sustained by GluN2A subunit-containing NMDARs alone [<xref ref-type="bibr" rid="B93-ijms-21-01538">93</xref>], suggesting that unique interactions may occur. This idea seems to be confirmed by another study, in which a GluN2A C-terminal truncation mouse model showed impaired tetanus-induced LTP [<xref ref-type="bibr" rid="B121-ijms-21-01538">121</xref>]. However, these mice have a reduction of the total levels of GluN2A, so it is possible that the LTP impairment is caused by the reduction in calcium influx (threshold effect) rather than the loss of the signaling downstream GluN2A. Also, in this case [<xref ref-type="bibr" rid="B121-ijms-21-01538">121</xref>], and in another study [<xref ref-type="bibr" rid="B122-ijms-21-01538">122</xref>], using more intense stimulation protocols overcomes the LTP induction deficit, probably thanks to the expected increase of calcium influx in the spine. To conclude, these experimental data indicate an involvement of GluN2A in LTP but there is no clear indication for a privileged or necessary role of this subunit in the process induction.</p>
<p>GluN2A has a bidirectional involvement in synaptic plasticity: it regulates and is regulated by it. In particular, LTP is a potent trigger of GluN2A upregulation, especially at synaptic levels. Several evidences seem to indicate that GluN2A rise in the postsynapse is associated to an early mobilization of NMDARs localized in non-synaptic pools and a later increase of total level of the protein. In adult rats HFS-induced LTP is coupled to waves of GluN2A increase in DG total homogenates: a rapid surge 20 min after LTP induction, then the subunit levels go back to the base levels 1h and 4h after LTP to go up again 24h after induction [<xref ref-type="bibr" rid="B43-ijms-21-01538">43</xref>]. LTP induced by HFS is also able to promote a GluN2B- to GluN2A-mediated current switch in newborn mice hippocampal slices, in a very short time window [<xref ref-type="bibr" rid="B123-ijms-21-01538">123</xref>]. Accordingly, LTP induction increased GluN2A synaptic levels in both hippocampal organotypic cultures from neonatal rats [<xref ref-type="bibr" rid="B12-ijms-21-01538">12</xref>] and in synaptosomal fractions of hippocampal slices from 6- to 8-week-old rats [<xref ref-type="bibr" rid="B124-ijms-21-01538">124</xref>]. Similarly, Franchini et al. found also in primary hippocampal cultures a synaptic increase of GluN2A driven by chemically induced LTP protocol, with a concurrent increase of its CTD-binding partner Rph3A (see <xref ref-type="fig" rid="ijms-21-01538-f001">Figure 1</xref>). Interestingly, interfering with GluN2A/Rph3A interaction prevents the synaptic increase of GluN2A levels [<xref ref-type="bibr" rid="B125-ijms-21-01538">125</xref>].</p>
<p>Baez and coworkers found that only after the establishment of an actual long-term potentiation (after 70 min), but not after 30 min, GluN2A levels were increased [<xref ref-type="bibr" rid="B126-ijms-21-01538">126</xref>]. Even if these data seem to contrast with the previously described ones, the different results obtained may arise from the different model used (young adult rats) and the different cellular fraction analyzed (hippocampal homogenates and not synaptic fractions). In accordance, GluN2A mRNA dendritic levels and translation increased 30 min after NMDA stimulation [<xref ref-type="bibr" rid="B127-ijms-21-01538">127</xref>], whereas LTP induction immediately increases local translation and membrane insertion of GluN2A and for the 30 min after the induction [<xref ref-type="bibr" rid="B128-ijms-21-01538">128</xref>]. </p>
<p>In conclusion, GluN2A seems to respond to the appropriate stimulus with a fast lateral mobilization from extra-synaptic to synaptic sites and, to sustain synaptic potentiation, with an increase of the local translation and surface expression at longer time points.</p>
</sec>
<sec id="sec4dot2-ijms-21-01538">
<title>4.2. Role of GluN2A in LTD</title>
<p>As described above, the exact nature of the role of GluN2A in the LTP process is still not completely clear. Similarly, it is still not possible to make an educated guess on the exact role of GluN2A in LTD, as there are contradictory results on the matter. Some studies using the pharmacological approach revealed that a concentration of NVP-AAM077 that is able to impair LTP does not affect LTD in culture [<xref ref-type="bibr" rid="B129-ijms-21-01538">129</xref>], in acute slices [<xref ref-type="bibr" rid="B110-ijms-21-01538">110</xref>], or in vivo [<xref ref-type="bibr" rid="B130-ijms-21-01538">130</xref>], suggesting that GluN2A is not necessary for LTD. However, there are other studies in opposition, in which the antagonist blocked LTD at the same concentration in which blocked LTP [<xref ref-type="bibr" rid="B112-ijms-21-01538">112</xref>,<xref ref-type="bibr" rid="B113-ijms-21-01538">113</xref>]. In another in vivo study, mice injected intraperitoneally with two different concentrations of NVP-AAM077 that were able to block LTP showed LTD impairments just at the higher concentration [<xref ref-type="bibr" rid="B114-ijms-21-01538">114</xref>], suggesting that just a substantial reduction in NMDAR-mediated current and subsequent calcium entry is able to perturb LTD induction, whereas at low concentration of NVP-AAM077, the residual calcium influx is not able to trigger LTP but is still able to mediate LTD. Also, genetic approaches, providing mostly negative results, did not provide a convincing answer to the question. No LTD deficit was found in GluN2A knockout mice [<xref ref-type="bibr" rid="B131-ijms-21-01538">131</xref>] and neither in case of direct [<xref ref-type="bibr" rid="B132-ijms-21-01538">132</xref>] nor indirect GluN2A overexpression [<xref ref-type="bibr" rid="B133-ijms-21-01538">133</xref>] at 1 Hz stimulation protocol, although at 3–5 Hz, GluN2A overexpression reduced LTD without affecting LTP [<xref ref-type="bibr" rid="B132-ijms-21-01538">132</xref>]. It was demonstrated that NMDAR-mediated ion flux block could not stop LTD induction, suggesting the emerging idea that the basal state of the spine, rather than the amount of the calcium influx through NMDARs, is essential for LTD. However, to what extent GluN2A is involved in LTD, if through the intracellular association or the channel properties conferred to the NMDAR, it is still not determined, even if the data provided do not evidence a necessary role of the subunit in the process.</p>
</sec>
<sec id="sec4dot3-ijms-21-01538">
<title>4.3. Role of GluN2A Interactors in Synaptic Plasticity</title>
<p>Despite GluN2A important role mediated by the particular channel properties it confers to the NMDAR, data seem to point out that many of the GluN2A specific effects, both in and out of the context of synaptic plasticity, may be due to the unique intracellular interactors that mediate GluN2A specific signaling pathways. First, as already described, some GluN2A CTD associated proteins are scaffolding proteins and mediate GluN2A membrane association and synaptic localization (See <xref ref-type="fig" rid="ijms-21-01538-f001">Figure 1</xref>). It was reported that Rph3A promotes stabilization of GluN2A-containing NMDARs in the postsynapse [<xref ref-type="bibr" rid="B71-ijms-21-01538">71</xref>]. Franchini et al. recently published that Rph3A is targeted to the synapse after chemically induced LTP, which, in turn, drives the upregulation of GluN2A-containing NMDAR induced by LTP through the formation of the Rph3A-GluN2A-PSD-95 complex. Remarkably Rhp3A silencing in vitro blocks LTP induction. Interfering with Rph3A/GluN2A interaction produces the same effect and in vivo induces a strong memory deficit [<xref ref-type="bibr" rid="B125-ijms-21-01538">125</xref>]. Other important interactors of GluN2A CTD that modulate its function in synaptic plasticity are protein kinases. Cdk5 can upregulate GluN2A function via phosphorylating GluN2A at Ser1232 in vitro and in vivo [<xref ref-type="bibr" rid="B87-ijms-21-01538">87</xref>]. CaMKIIα competes with PSD-95 for binding to GluN2A [<xref ref-type="bibr" rid="B79-ijms-21-01538">79</xref>]. This interaction occurs with non-phosphorylated CaMKII, but is positively regulated by kinase autophosphorylation [<xref ref-type="bibr" rid="B86-ijms-21-01538">86</xref>]. CaMKII activity has been demonstrated to be necessary and sufficient for LTP induction (reviewed in [<xref ref-type="bibr" rid="B134-ijms-21-01538">134</xref>]). Finally, GluN2A has the unique association with the synaptonuclear messenger RNF10 (see <xref ref-type="fig" rid="ijms-21-01538-f001">Figure 1</xref>) that has been demonstrated to mediate GluN2A-mediated LTP maintenance as well as LTP-dependent structural modifications of dendritic spines [<xref ref-type="bibr" rid="B76-ijms-21-01538">76</xref>]. More recently Carrano et al. demonstrated a wider role of the GluN2A-associated synaptonuclear communication mediated by RNF10 in the regulation of dendritic arborization [<xref ref-type="bibr" rid="B135-ijms-21-01538">135</xref>]. </p>
</sec>
</sec>
<sec id="sec5-ijms-21-01538">
<title>5. Role of GluN2A in Learning and Memory</title>
<p>Synaptic plasticity is considered the cellular and molecular basis for learning and memory formation [<xref ref-type="bibr" rid="B136-ijms-21-01538">136</xref>,<xref ref-type="bibr" rid="B137-ijms-21-01538">137</xref>] and several studies have demonstrated an important role for NMDARs in specific forms of learning and memory [<xref ref-type="bibr" rid="B138-ijms-21-01538">138</xref>,<xref ref-type="bibr" rid="B139-ijms-21-01538">139</xref>]. The specific involvement of GluN2A in learning and memory has been investigated through both pharmacological and genetical approaches. Genetic ablation of GluN2A and expression of a GluN2A lacking the CTD did not impair spatial tasks acquired over a number of days (the Morris water maze (MWM) and radial arm maze) [<xref ref-type="bibr" rid="B140-ijms-21-01538">140</xref>]. Neto1 knockout mice, characterized by reduced level of GluN2A and LTP deficits, perform normally at MWM [<xref ref-type="bibr" rid="B118-ijms-21-01538">118</xref>]. Pharmacological manipulations gave similar results: intraperitoneal injections of the GluN2A antagonist NVP-AAM077, able to block LTP, in vivo did not alter MWM acquisition or consolidation in rats [<xref ref-type="bibr" rid="B130-ijms-21-01538">130</xref>]. However, interfering with GluN2A has been associated with short-term memory deficits. In fact, GluN2A-knockout or GluN2A C-terminus-deficient mice exhibit impaired spatial working memory [<xref ref-type="bibr" rid="B140-ijms-21-01538">140</xref>]. Moreover, CA1 infusion of NVP-AAM077 impaired the performance on a delayed alternation T-maze task [<xref ref-type="bibr" rid="B141-ijms-21-01538">141</xref>]. Other works suggested that GluN2A might participate in the rapid acquisition of context or object representations. Indeed, GluN2A knockout mice showed an impaired performance in a variant of a hippocampus-dependent contextual fear-conditioning with reduced context exposure before shock delivery [<xref ref-type="bibr" rid="B120-ijms-21-01538">120</xref>]. Moreover, Neto1 knockout mice were impaired in a displaced object recognition task, but not in a novel object recognition task, suggesting a specific deficit in a hippocampal dependent test [<xref ref-type="bibr" rid="B118-ijms-21-01538">118</xref>]. Similarly, Franchini et al. found that mice treated with a cell-permeable peptide that interferes with Rph3A-mediated GluN2A synaptic delivery also display memory defects in the object displacement task [<xref ref-type="bibr" rid="B125-ijms-21-01538">125</xref>]. </p>
<p>Thus, GluN2A does not seem necessary for incrementally acquired long-term memory tasks. It seems that GluN2A partially controls learning and memory: it is not necessary for long-term memory tasks but seems to affect short-term memory and the rapid acquisition of spatial information.</p>
<p>However, it is interesting to note that pharmacological and genetic manipulations of the GluN2B subunit produce similar cognitive alterations of the ones described by manipulating GluN2A, suggesting that a general reduction in NMDAR-mediated current might induce short-term memory deficits, rather than specifically interfering with GluN2A-containing NMDAR.</p>
<p>NMDAR has been subject of study also in the context of fear memory. Even if most of the studies support the idea that GluN2B is the subunit that is primarily involved in this kind of memory process [<xref ref-type="bibr" rid="B142-ijms-21-01538">142</xref>,<xref ref-type="bibr" rid="B143-ijms-21-01538">143</xref>,<xref ref-type="bibr" rid="B144-ijms-21-01538">144</xref>,<xref ref-type="bibr" rid="B145-ijms-21-01538">145</xref>,<xref ref-type="bibr" rid="B146-ijms-21-01538">146</xref>], recently some studies have also pointed out an involvement of GluN2A-containing NMDARs. The group of Luo demonstrated that interfering with the activity-dependent insertion of GluN2A mediated by the ER chaperone Bip in the dorsal hippocampus was sufficient to impair the acquisition of fear conditioning test, suggesting that the interaction between the two proteins is crucial for fear memory formation [<xref ref-type="bibr" rid="B107-ijms-21-01538">107</xref>]. Moreover, an increase of GluN2A/GluN2B ratio in basolateral amygdala after fear memory consolidation inhibits retrieval-dependent memory destabilization and modification of the fear memory trace, suggesting a neurobiological molecular explanation of why some memory events are resistant to variation and extinction [<xref ref-type="bibr" rid="B147-ijms-21-01538">147</xref>]. Similarly to synaptic plasticity, the process of learning and memory also influences GluN2A. A hippocampal-dependent spatial memory task, MWM, was shown to upregulate GluN2A mRNA levels after the training session. Baez et al. showed an increase in GluN2A levels in the hippocampi in habituation of a new environment starting from 30 min after the test [<xref ref-type="bibr" rid="B126-ijms-21-01538">126</xref>]. Interestingly, a similar upregulation of GluN2A was also found after each phase of object presentation of the novel object recognition task [<xref ref-type="bibr" rid="B24-ijms-21-01538">24</xref>]. This evidence supports the idea that specific types of memory are supported by a contribution of GluN2A-containing NMDAR mediated neurotransmission and so the subunit is upregulated by the process itself. </p>
</sec>
<sec id="sec6-ijms-21-01538">
<title>6. Role of GluN2A in Pathological Plasticity</title>
<p>Modifications of the GluN2A-containing NMDARs have been implicated in several pathological conditions including among others cerebral ischemia [<xref ref-type="bibr" rid="B148-ijms-21-01538">148</xref>], depression [<xref ref-type="bibr" rid="B149-ijms-21-01538">149</xref>,<xref ref-type="bibr" rid="B150-ijms-21-01538">150</xref>,<xref ref-type="bibr" rid="B151-ijms-21-01538">151</xref>,<xref ref-type="bibr" rid="B152-ijms-21-01538">152</xref>,<xref ref-type="bibr" rid="B153-ijms-21-01538">153</xref>,<xref ref-type="bibr" rid="B154-ijms-21-01538">154</xref>,<xref ref-type="bibr" rid="B155-ijms-21-01538">155</xref>,<xref ref-type="bibr" rid="B156-ijms-21-01538">156</xref>], anxiety [<xref ref-type="bibr" rid="B149-ijms-21-01538">149</xref>,<xref ref-type="bibr" rid="B157-ijms-21-01538">157</xref>], schizophrenia [<xref ref-type="bibr" rid="B158-ijms-21-01538">158</xref>,<xref ref-type="bibr" rid="B159-ijms-21-01538">159</xref>,<xref ref-type="bibr" rid="B160-ijms-21-01538">160</xref>,<xref ref-type="bibr" rid="B161-ijms-21-01538">161</xref>], and Huntington’s disease [<xref ref-type="bibr" rid="B162-ijms-21-01538">162</xref>,<xref ref-type="bibr" rid="B163-ijms-21-01538">163</xref>,<xref ref-type="bibr" rid="B164-ijms-21-01538">164</xref>]. In this review we decided to focus our attention on selected brain disorders in which GluN2A disfunctions is strictly correlated to altered synaptic plasticity, such as epilepsy, Alzheimer’s disease, Parkinson’s disease, Fragile-X Syndrome, and autism.</p>
<sec id="sec6dot1-ijms-21-01538">
<title>6.1. GluN2A in Epilepsy</title>
<p>Epilepsy represents a common disease in the population with complex pathophysiology leading to aberrant firing in brain circuits [<xref ref-type="bibr" rid="B165-ijms-21-01538">165</xref>]. Several mutations of <italic>GRIN2A</italic> (encoding the GluN2A subunit) leading to NMDAR gain- or loss-of-function have been associated with different epilepsy-aphasia spectrum (EAS) such as benign epilepsy with centrotemporal spikes (BECTS), the Landau–Kleffner syndrome (LKS) and epileptic encephalopathy with continuous-spike-and-waves-during-slow-wave-sleep (CSWSS) [<xref ref-type="bibr" rid="B166-ijms-21-01538">166</xref>,<xref ref-type="bibr" rid="B167-ijms-21-01538">167</xref>,<xref ref-type="bibr" rid="B168-ijms-21-01538">168</xref>]. A patient with the GluN2A P552R substitution presented seizures and intellectual disability [<xref ref-type="bibr" rid="B169-ijms-21-01538">169</xref>]. This mutation affects the pre-M1 region of GluN2A leading to higher glutamate and glycine potency of the NMDAR, without impairments in receptor surface trafficking or expression. Hippocampal primary cultures transfected with this receptor variant showed increased neurotoxicity under synaptic stimulation conditions, which was rescued by memantine, underlining the contribution of this mutation to the clinical phenotype observed [<xref ref-type="bibr" rid="B170-ijms-21-01538">170</xref>]. Other mutations associated with epilepsy, the GluN2A M817V as well as the L812M substitution which both reside in the pre-M4 region [<xref ref-type="bibr" rid="B171-ijms-21-01538">171</xref>,<xref ref-type="bibr" rid="B172-ijms-21-01538">172</xref>], increase agonist potency, channel mean open time and open probability while reducing endogenous negative modulator effects on receptor activity [<xref ref-type="bibr" rid="B173-ijms-21-01538">173</xref>]. A GluN2A mutation at Tyr1387 was reported in a family displaying CSWSS and an autistic phenotype [<xref ref-type="bibr" rid="B167-ijms-21-01538">167</xref>]. Interestingly, Tyr1387 is a well-known GluN2A phosphorylation site by Src Kinase, important for the modulation of the receptor activity [<xref ref-type="bibr" rid="B174-ijms-21-01538">174</xref>]. </p>
<p>Other <italic>GRIN2A</italic> mutations such as the GluN2A-I148S and R512H were associated with reduced surface NMDAR expression, activation time and current amplitude, when expressed in heterozygous or homozygous condition in HEK cells [<xref ref-type="bibr" rid="B175-ijms-21-01538">175</xref>]. Overall, GluN2A-I148S and R512H can be considered dominant negative variants of GluN2A, as well as the I184T, C436R, R518H, T531M, V685G, and D731N [<xref ref-type="bibr" rid="B175-ijms-21-01538">175</xref>,<xref ref-type="bibr" rid="B176-ijms-21-01538">176</xref>,<xref ref-type="bibr" rid="B177-ijms-21-01538">177</xref>,<xref ref-type="bibr" rid="B178-ijms-21-01538">178</xref>]. Moreover, also the GluN2A-N651K variant previously described (see NMDAR structure paragraph) can be considered as a dominant negative form of the GluN2A subunit due to low Ca<sup>2+</sup> influx in spite of low Mg<sup>2+</sup> sensitivity [<xref ref-type="bibr" rid="B53-ijms-21-01538">53</xref>]. Finally, there are some GluN2A mutations that are also present in GluN2B (equivalent sites) but give rise to different phenotypes. In particular, the GluN2A variants C436R, V685G, and D731N were shown to induce intractable epilepsy with developmental delay and general tonic-clonic seizures [<xref ref-type="bibr" rid="B167-ijms-21-01538">167</xref>,<xref ref-type="bibr" rid="B176-ijms-21-01538">176</xref>,<xref ref-type="bibr" rid="B177-ijms-21-01538">177</xref>], whereas GluN2B ones (C436R, Q413G, and C461F) with intellectual disability and absence seizures [<xref ref-type="bibr" rid="B178-ijms-21-01538">178</xref>,<xref ref-type="bibr" rid="B179-ijms-21-01538">179</xref>,<xref ref-type="bibr" rid="B180-ijms-21-01538">180</xref>].</p>
<p>However, the involvement of GluN2A subunit in epilepsy has been correlated not only to genetical variants, but also to altered trafficking, expression and balance with other NMDAR subunits for an adequate receptor functioning. </p>
<p>Injection of convulsive agents, such as 3-mercaptopropionic acid or 4-aminopyridine for several days, is able to increase hippocampal GluN2A levels [<xref ref-type="bibr" rid="B181-ijms-21-01538">181</xref>,<xref ref-type="bibr" rid="B182-ijms-21-01538">182</xref>]. Chen and colleagues demonstrated how selective antagonism of the GluN2 subunits is neuroprotective in the hippocampus of pilocarpine and kindling animal models of epilepsy. However, only GluN2A antagonism reduced epileptogenesis, seizure-induced mossy fiber sprouting, and the activity-dependent BDNF expression indicating a crucial role of this subunit in epilepsy [<xref ref-type="bibr" rid="B183-ijms-21-01538">183</xref>]. Recently, activation of GPR40 (a Gq coupled GPCR) in the kainic-acid (KA) induced epilepsy model and PTZ-kindling model reduced susceptibility to SE, most probably reducing NMDAR surface localization by regulating the endocytosis of the receptor [<xref ref-type="bibr" rid="B184-ijms-21-01538">184</xref>]. </p>
<p>A characteristic of some epilepsy models is that a single application of convulsive agent (electrical stimulation, GABA-A receptor antagonist, and Kainic Acid) has a long-term impact on electrical activity of the model itself, even after a washout period. Abegg and colleagues revealed how the Bicuculline (GABA-A receptor antagonist) epilepsy model induces abnormal LTP-like phenotype by exaggerated potentiation of excitatory synapses [<xref ref-type="bibr" rid="B185-ijms-21-01538">185</xref>]. In particular, they observed how NMDAR activity was responsible for synapse potentiation by increasing synaptic AMPAR insertion, then occluding LTP induction but enhancing LTD amplitude in CA1. In this study, they provided a probable explanation for impaired learning abilities after epileptic exposure [<xref ref-type="bibr" rid="B186-ijms-21-01538">186</xref>,<xref ref-type="bibr" rid="B187-ijms-21-01538">187</xref>,<xref ref-type="bibr" rid="B188-ijms-21-01538">188</xref>]. However, more recent literature identified both increased [<xref ref-type="bibr" rid="B189-ijms-21-01538">189</xref>,<xref ref-type="bibr" rid="B190-ijms-21-01538">190</xref>,<xref ref-type="bibr" rid="B191-ijms-21-01538">191</xref>] and decreased LTP responses, probably depending on experimental conditions and how efficiently the seizure-induced LTP-like condition was realized [<xref ref-type="bibr" rid="B192-ijms-21-01538">192</xref>,<xref ref-type="bibr" rid="B193-ijms-21-01538">193</xref>,<xref ref-type="bibr" rid="B194-ijms-21-01538">194</xref>]. Finally, in a recent work Hanson et al. found that the seizure phenotype was ameliorated by the use of a Positive Allosteric Modulator of GluN2A in a mouse model of Dravet syndrome [<xref ref-type="bibr" rid="B195-ijms-21-01538">195</xref>]. In this case, the activation of GluN2A-containing NMDAR was able to improve the brain oscillations and neuronal hypersynchrony, improving the epileptic discharges. </p>
</sec>
<sec id="sec6dot2-ijms-21-01538">
<title>6.2. GluN2A in Autism Spectrum Disorder (ASD) and in Fragile X Syndrome (FXS)</title>
<p>Neurodevelopmental disorders characterized by reduced learning and social abilities are also called Intellectual Disabilities (IDs). Among IDs, ASD shows high variability in the severity of social-deficit interaction, communication, and stereotyped behaviors [<xref ref-type="bibr" rid="B196-ijms-21-01538">196</xref>,<xref ref-type="bibr" rid="B197-ijms-21-01538">197</xref>,<xref ref-type="bibr" rid="B198-ijms-21-01538">198</xref>]. Genetic background as well as environmental exposure to different stressors play an impact on the disease emergence [<xref ref-type="bibr" rid="B199-ijms-21-01538">199</xref>,<xref ref-type="bibr" rid="B200-ijms-21-01538">200</xref>]. FXS is an X-linked disease characterized by IDs and often accompanied by autistic features. In particular, FXS is due to lack or altered expression in <italic>FMR1</italic> gene, encoding Fragile Mental Retardation Protein (FMRP), which binds mRNA [<xref ref-type="bibr" rid="B201-ijms-21-01538">201</xref>] and regulates its transport and translation [<xref ref-type="bibr" rid="B202-ijms-21-01538">202</xref>,<xref ref-type="bibr" rid="B203-ijms-21-01538">203</xref>].</p>
<p>Among the several neuronal alterations detected in ASD and FXS, a convergent point is dysregulation in synaptic protein expression and activity, leading to altered intracellular signaling during neurotransmission. Interestingly, FMRP target mRNAs include both pre and postsynaptic proteins such as NMDARs, PSD-95, Shank1-3, Calcium channels, SNAP-25, and many others [<xref ref-type="bibr" rid="B204-ijms-21-01538">204</xref>]. </p>
<p>In particular, NMDAR and mGluR signaling modulating ERK/MAPK kinase activity have been associated with the pathophysiology of FXS [<xref ref-type="bibr" rid="B205-ijms-21-01538">205</xref>]. Indeed, FXS-patient brain and Fmr1-KO mouse model show hyperactive ERK/MAPK pathway [<xref ref-type="bibr" rid="B206-ijms-21-01538">206</xref>,<xref ref-type="bibr" rid="B207-ijms-21-01538">207</xref>]. Furthermore, elevated activation of ERK was detected in Fmr1-KO mice and associated to overproduction of APPα derived from APP cleavage [<xref ref-type="bibr" rid="B208-ijms-21-01538">208</xref>]. </p>
<p>Synaptic plasticity events in different regions of Fmr1-KO animals are altered compared to WT. In particular, the LTP in CA1 region of hippocampus is impaired in animal models of FXS [<xref ref-type="bibr" rid="B209-ijms-21-01538">209</xref>,<xref ref-type="bibr" rid="B210-ijms-21-01538">210</xref>] as well as in other brain regions [<xref ref-type="bibr" rid="B211-ijms-21-01538">211</xref>,<xref ref-type="bibr" rid="B212-ijms-21-01538">212</xref>,<xref ref-type="bibr" rid="B213-ijms-21-01538">213</xref>,<xref ref-type="bibr" rid="B214-ijms-21-01538">214</xref>,<xref ref-type="bibr" rid="B215-ijms-21-01538">215</xref>]. Importantly, Lundbye and colleagues recently reported the NMDAR-dependent LTP in CA1 of Fmr1-KO animals was restored to normal levels with selective inhibition of GluN2A subunit through different antagonists and negative allosteric modulators (NAM) or via GRIN2A deletion [<xref ref-type="bibr" rid="B216-ijms-21-01538">216</xref>].</p>
<p>mGluR1/5-dependent LTD in CA1 was reported to be enhanced in Fmr1-KO animals compared to WT [<xref ref-type="bibr" rid="B216-ijms-21-01538">216</xref>,<xref ref-type="bibr" rid="B217-ijms-21-01538">217</xref>,<xref ref-type="bibr" rid="B218-ijms-21-01538">218</xref>,<xref ref-type="bibr" rid="B219-ijms-21-01538">219</xref>]. Interestingly, mGluR1/5 LTD was also recovered to basal levels via GluN2A inhibition [<xref ref-type="bibr" rid="B216-ijms-21-01538">216</xref>]. </p>
<p>A reduction of both LTP [<xref ref-type="bibr" rid="B217-ijms-21-01538">217</xref>] and NMDAR-mediated LTD [<xref ref-type="bibr" rid="B220-ijms-21-01538">220</xref>] were also recorded in perforant path-granule cells of Fmr1-KO animals. In agreement with the DG involvement in pattern separation aspects of learning [<xref ref-type="bibr" rid="B221-ijms-21-01538">221</xref>], Fmr1-KO mice display no impairments in acquisition phase of Morris Water Maze [<xref ref-type="bibr" rid="B222-ijms-21-01538">222</xref>,<xref ref-type="bibr" rid="B223-ijms-21-01538">223</xref>], but have reduced context discrimination and altered memory extinction [<xref ref-type="bibr" rid="B222-ijms-21-01538">222</xref>,<xref ref-type="bibr" rid="B224-ijms-21-01538">224</xref>], which is thought to be dependent on NMDAR-LTD [<xref ref-type="bibr" rid="B225-ijms-21-01538">225</xref>]. </p>
<p>Recently, integrated transcriptome analysis revealed, among other genes, alterations of <italic>GRIN2A</italic> in the adult hippocampus of ASD mouse models [<xref ref-type="bibr" rid="B226-ijms-21-01538">226</xref>], strengthening its role in the pathophysiology of neurodevelopmental disorders. </p>
</sec>
<sec id="sec6dot3-ijms-21-01538">
<title>6.3. Pathological Synaptic Plasticity in Parkinson’s Disease and Dystonia</title>
<p>A balanced cross-talk between dopaminergic and glutamatergic transmission in the striatum is essential for corticostriatal synaptic plasticity and motor activity [<xref ref-type="bibr" rid="B227-ijms-21-01538">227</xref>]. In Parkinson’s disease, the degeneration of nigrostriatal dopaminergic neurons leads to complex alterations of the basal ganglia pathways involving also impaired synaptic plasticity of striatal spiny projecting neurons (SPNs) [<xref ref-type="bibr" rid="B228-ijms-21-01538">228</xref>]. SPNs express GluN2A- and GluN2B-containing NMDARs [<xref ref-type="bibr" rid="B229-ijms-21-01538">229</xref>,<xref ref-type="bibr" rid="B230-ijms-21-01538">230</xref>] and an alteration of GluN2A/GluN2B subunit ratio of the striatal synaptic NMDAR is a key element in the regulation of motor behavior and synaptic plasticity in PD [<xref ref-type="bibr" rid="B231-ijms-21-01538">231</xref>,<xref ref-type="bibr" rid="B232-ijms-21-01538">232</xref>]. Interestingly, distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition [<xref ref-type="bibr" rid="B231-ijms-21-01538">231</xref>]. The complete depletion of striatal DA induces in the PD rat model by 6OHDA, mimicking advanced stages of the disease, results in the loss of both LTP and LTD and an increase of GluN2A/GluN2B ratio at synapses [<xref ref-type="bibr" rid="B230-ijms-21-01538">230</xref>,<xref ref-type="bibr" rid="B231-ijms-21-01538">231</xref>]. However, an early PD model characterized by only a partial DA depletion and mild motor symptoms shows a normal LTD and an altered LTP associated with a selective increased expression of synaptic GluN2A NMDARs. The use of cell permeable peptides able to modulate GluN2A interaction with scaffolding elements and, consequently, a physiological NMDAR subunit composition led to a full rescue of synaptic plasticity and to an amelioration of the motor behavior [<xref ref-type="bibr" rid="B231-ijms-21-01538">231</xref>]. Overall, these studies indicate that an uncorrected composition of NMDARs is a key element in both motor behavior and synaptic plasticity in experimental PD. </p>
<p>Notably, more recent studies suggest that also α-synuclein (α-syn) produces deficits in visuospatial learning and impairs LTP in striatal SPNs belonging to the direct and indirect basal ganglia pathways by altering the activity and synaptic localization of GluN2A-containing NMDARs [<xref ref-type="bibr" rid="B233-ijms-21-01538">233</xref>]. In addition, α-syn impairs NMDAR-dependent LTP in striatal SPNs without inducing any effect on LTD [<xref ref-type="bibr" rid="B233-ijms-21-01538">233</xref>], in agreement with previous reports showing that this latter form of synaptic plasticity in the striatum does not require NMDAR activation [<xref ref-type="bibr" rid="B228-ijms-21-01538">228</xref>]. Similarly, also in hippocampal neurons α-syn oligomers impair LTP and modify basal synaptic transmission through an NMDAR-mediated mechanism [<xref ref-type="bibr" rid="B234-ijms-21-01538">234</xref>]. Even if levodopa remains the major pharmacological approach for Parkinson’s disease, patients treated for several years develop disabling motor complications known as levodopa-induced dyskinesia [<xref ref-type="bibr" rid="B235-ijms-21-01538">235</xref>]. These events are strictly correlated to adaptive changes of the glutamatergic corticostriatal signaling and involve also an aberrant functioning of NMDARs. Accordingly, the use of the low-affinity noncompetitive NMDAR antagonist amantadine allows at least a short-term benefit in the treatment of dyskinesia [<xref ref-type="bibr" rid="B235-ijms-21-01538">235</xref>,<xref ref-type="bibr" rid="B236-ijms-21-01538">236</xref>]. Of relevance, chronic levodopa treatment restores bidirectional synaptic plasticity (LTD, LTP, and depotentiation) only in non-dyskinetic conditions, whereas both in animal models and in patients, dyskinesias are associated with the loss of depotentiation of previously induced LTP [<xref ref-type="bibr" rid="B210-ijms-21-01538">210</xref>,<xref ref-type="bibr" rid="B237-ijms-21-01538">237</xref>,<xref ref-type="bibr" rid="B238-ijms-21-01538">238</xref>]. </p>
<p>Several reports demonstrated an increased synaptic GluN2A/GluN2B ratio of NMDARs in dendritic spines of SPNs, both in animal models and in patients [<xref ref-type="bibr" rid="B230-ijms-21-01538">230</xref>,<xref ref-type="bibr" rid="B232-ijms-21-01538">232</xref>,<xref ref-type="bibr" rid="B239-ijms-21-01538">239</xref>], paralleled by modifications in the association of GluN2-type subunits with scaffolding proteins. Interestingly, treatment with peptides disrupting GluN2A interaction with MAGUK proteins or with Rph3A demonstrated that a decrease in synaptic GluN2A-containing NMDAR is sufficient to induce a significant reduction in the severity of Levodopa-induced dyskinesia [<xref ref-type="bibr" rid="B240-ijms-21-01538">240</xref>,<xref ref-type="bibr" rid="B241-ijms-21-01538">241</xref>]. </p>
<p>Alterations of synaptic plasticity have been reported as a key determinant in the pathophysiology of early-onset generalized torsion dystonia (DYT1), an autosomal dominant movement disorder [<xref ref-type="bibr" rid="B242-ijms-21-01538">242</xref>]. Human studies identified modifications of neuronal processing and plasticity in dystonic patients [<xref ref-type="bibr" rid="B243-ijms-21-01538">243</xref>] and an impairment of striatal plasticity has been shown in different DYT1 animal models. In particular, a recent study demonstrated in a DYT1 dystonia mouse model that LTP appeared prematurely in a critical developmental window in striatal SPNs, whereas LTD was never recorded [<xref ref-type="bibr" rid="B244-ijms-21-01538">244</xref>]. Notably these functional alterations where closely related to an increase of postsynaptic GluN2A suggesting a “premature” GluN2A/GluN2B switch [<xref ref-type="bibr" rid="B244-ijms-21-01538">244</xref>].</p>
</sec>
<sec id="sec6dot4-ijms-21-01538">
<title>6.4. Dysfunction of Glutamatergic Synaptic Plasticity in Alzheimer’s Disease</title>
<p>Dysfunction of the excitatory synapse and spine loss represent early functional and morphological events of Alzheimer’s disease (AD). Several postsynaptic proteins of the glutamatergic synapses have been demonstrated to be a key target of the amyloid-β<sub>1–42</sub> (Aβ<sub>1–42</sub>) peptide, whose accumulation and deposition are the main hallmarks of AD. Notably, several studies indicate that Aβ<sub>1–42</sub> is an important modulator of neuronal activity affecting in turn synaptic transmission and plasticity [<xref ref-type="bibr" rid="B245-ijms-21-01538">245</xref>]. In particular, oligomeric Aβ<sub>1–42</sub> can alter the activation of NMDARs and downstream signaling cascades promoting the loss of LTP, the induction of LTD, and synaptic loss [<xref ref-type="bibr" rid="B246-ijms-21-01538">246</xref>,<xref ref-type="bibr" rid="B247-ijms-21-01538">247</xref>,<xref ref-type="bibr" rid="B248-ijms-21-01538">248</xref>]. </p>
<p>The different contribution of GluN2A- and GluN2B-containing NMDARs to Aβ<sub>1–42</sub>-induced synaptic toxicity has been widely evaluated. Several studies reported the role of the extra-synaptic GluN2B-containing NMDARs in these events [<xref ref-type="bibr" rid="B249-ijms-21-01538">249</xref>,<xref ref-type="bibr" rid="B250-ijms-21-01538">250</xref>,<xref ref-type="bibr" rid="B251-ijms-21-01538">251</xref>]. Aβ<sub>1–42</sub> oligomers induce intracellular Ca<sup>2+</sup> overload particularly mediated by the GluN2A subunit and neuronal death that can be prevented by NMDAR antagonists [<xref ref-type="bibr" rid="B252-ijms-21-01538">252</xref>]. In addition, another study showed that presenilin knockout mice models are characterized by an early increase in GluN2A-containing NMDARs at the PSD with a concomitant reduction at non-synaptic sites before synaptic loss [<xref ref-type="bibr" rid="B253-ijms-21-01538">253</xref>]. Moreover, oligomeric Aβ<sub>1–42</sub> caused selective loss of synaptic GluN2B responses, promoting a switch in subunit composition from GluN2B to GluN2A, a process normally observed during development [<xref ref-type="bibr" rid="B254-ijms-21-01538">254</xref>]. As GluN2A subunits have been implicated in protective pathways, whereas GluN2B subunits appear to increase neuronal vulnerability [<xref ref-type="bibr" rid="B255-ijms-21-01538">255</xref>], the early increase in GluN2A and decrease in GluN2B subunit-composed NMDARs activity may be an attempt to reduce Aβ<sub>1–42</sub>-induced neuronal dysfunction. Finally, a very recent study provided a novel mechanistic explanation for Aβ<sub>1–42</sub>-dependent aberrant plasticity induced oligomeric forms [<xref ref-type="bibr" rid="B256-ijms-21-01538">256</xref>]. In particular, Marcello and co-workers demonstrated that oligomeric Aβ<sub>1–42</sub> activates a pathway that requires neuronal activity and the involvement of the GluN2A-containing NMDARs. Moreover, Aβ<sub>1–42</sub>-induced neuronal degeneration involves activation of extrasynaptic GluN2B-containing NMDARs followed by increased Tau phosphorylation, whereas spine loss can be mainly mediated by GluN2A-containing NMDARs signaling and active caspase-3 [<xref ref-type="bibr" rid="B257-ijms-21-01538">257</xref>]. Noteworthy, among Aβ toxicity mechanisms, also NMDAR metabotropic signaling was shown to impact on synaptic functions. However, this process seems to mainly involve GluN2B-containing NMDARs as reported by Malinow’s laboratory in 2013 [<xref ref-type="bibr" rid="B254-ijms-21-01538">254</xref>]. However, Aβ treatment was also found to act indirectly on GluN2A subunit, increasing the synaptic GluN2A/GluN2B ratio [<xref ref-type="bibr" rid="B254-ijms-21-01538">254</xref>] and so inducing a switch in NMDAR subunits similar to the neurodevelopmental one.</p>
<p>The impact of GluN2A subunit in AD has been recently taken into account also as a potential pharmacological target. In particular, GNE-0723, a novel positive allosteric modulator of GluN2A-containing NMDAR, was shown to ameliorate the cognitive deficits in a mouse model of AD (J20) [<xref ref-type="bibr" rid="B195-ijms-21-01538">195</xref>], supporting the importance of the involvement of synaptic NMDAR neurotransmission in AD pathogenesis. </p>
</sec>
</sec>
<sec id="sec7-ijms-21-01538" sec-type="conclusions">
<title>7. Conclusions</title>
<p>NMDARs have been intensively studied in the last decades because of their involvement in many aspects of neuronal transmission as well as learning and memory. It has been clearly demonstrated that NMDAR properties depend on its subunit composition and this review focused on the distinctive functions of synaptic GluN2A-containing NMDARs. Even if these NMDAR subtypes play a key role in both physiology and pathological synaptic plasticity, future studies aiming to understand their contribution to the pathophysiology of neurological disorders will require novel and specific approaches to overcome the limitations due to the high similarity among GluN2-type regulatory subunits. At present, genetic manipulation of GluN2A did not fully clarify its pathophysiological role and the available pharmacological tools are not specific enough to give a better answer. Understanding the role and the modulation of GluN2A protein–protein interactions at the CTD may provide new possible targets for pharmacological tools and be a future direction in which to investigate the unique role of this NMDAR subunit in the context of glutamatergic neurotransmission and synaptic plasticity.</p>
</sec>
</body>
<back>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflicts of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-ijms-21-01538">
<label>1.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Seeburg</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Burnashev</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Köhr</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kuner</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sprengel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Monyer</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The NMDA Receptor Channel: Molecular Design of a Coincidence Detector</article-title>
<source/>Proceedings of the 1993 Laurentian Hormone Conference
          <comment>Recent progress in hormone research</comment>
<publisher-name>Academic Press</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>1995</year>
<fpage>19</fpage>
<lpage>34</lpage>
</element-citation>
</ref>
<ref id="B2-ijms-21-01538">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Guthrie</surname>
<given-names>P.B.</given-names>
</name>
</person-group>
<article-title>Voltage-dependent block by Mg 2+ of NMDA responses in spinal cord neurones</article-title>
<source/>Nature
          <year>1984</year>
<volume>309</volume>
<fpage>261</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="doi">10.1038/309261a0</pub-id>
<pub-id pub-id-type="pmid">6325946</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-21-01538">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duguid</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sjöström</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>Novel presynaptic mechanisms for coincidence detection in synaptic plasticity</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2006</year>
<volume>16</volume>
<fpage>312</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2006.05.008</pub-id>
<pub-id pub-id-type="pmid">16713246</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-21-01538">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berretta</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>R.S.G.</given-names>
</name>
</person-group>
<article-title>Tonic facilitation of glutamate release by presynaptic N-methyl-D-aspartate autoreceptors in the entorhinal cortex</article-title>
<source/>Neuroscience
          <year>1996</year>
<volume>75</volume>
<fpage>339</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4522(96)00301-6</pub-id>
<pub-id pub-id-type="pmid">8931000</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-21-01538">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sjöström</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Turrigiano</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>S.B.</given-names>
</name>
</person-group>
<article-title>Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors</article-title>
<source/>Neuron
          <year>2003</year>
<volume>39</volume>
<fpage>641</fpage>
<lpage>654</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(03)00476-8</pub-id>
<pub-id pub-id-type="pmid">12925278</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-21-01538">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegel</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Brose</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Gasic</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Jahn</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Regional, cellular, and ultrastructural distribution of N-methyl-D- aspartate receptor subunit 1 in monkey hippocampus</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1994</year>
<volume>91</volume>
<fpage>564</fpage>
<lpage>568</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.91.2.564</pub-id>
<pub-id pub-id-type="pmid">8290563</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-21-01538">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGuinness</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>R.D.T.</given-names>
</name>
<name>
<surname>Yau</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Langenhan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Christian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tynan</surname>
<given-names>P.W.</given-names>
</name>
<name>
<surname>Donnelly</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Emptage</surname>
<given-names>N.J.</given-names>
</name>
</person-group>
<article-title>Presynaptic NMDARs in the Hippocampus Facilitate Transmitter Release at Theta Frequency</article-title>
<source/>Neuron
          <year>2010</year>
<volume>68</volume>
<fpage>1109</fpage>
<lpage>1127</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2010.11.023</pub-id>
<pub-id pub-id-type="pmid">21172613</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-21-01538">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casado</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dieudonné</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ascher</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Presynaptic N-methyl-D-aspartate receptors at the parallel fiber-Purkinje cell synapse</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2000</year>
<volume>97</volume>
<fpage>11593</fpage>
<lpage>11597</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.200354297</pub-id>
<pub-id pub-id-type="pmid">11016958</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-21-01538">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bidoret</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ayon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barbour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Casado</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Presynaptic NR2A-containing NMDA receptors implement a high-pass filter synaptic plasticity rule</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>14126</fpage>
<lpage>14131</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0904284106</pub-id>
<pub-id pub-id-type="pmid">19666514</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-21-01538">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Basbaum</surname>
<given-names>A.I.</given-names>
</name>
</person-group>
<article-title>Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1994</year>
<volume>91</volume>
<fpage>8383</fpage>
<lpage>8387</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.91.18.8383</pub-id>
<pub-id pub-id-type="pmid">8078891</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-21-01538">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vissel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Krupp</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>G.L.</given-names>
</name>
</person-group>
<article-title>A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux</article-title>
<source/>Nat. Neurosci.
          <year>2001</year>
<volume>4</volume>
<fpage>587</fpage>
<lpage>596</lpage>
<pub-id pub-id-type="doi">10.1038/88404</pub-id>
<pub-id pub-id-type="pmid">11369939</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-21-01538">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barria</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Subunit-Specific NMDA Receptor Trafficking to Synapses</article-title>
<source/>Neuron
          <year>2002</year>
<volume>35</volume>
<fpage>345</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(02)00776-6</pub-id>
<pub-id pub-id-type="pmid">12160751</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-21-01538">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.Q.</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kalia</surname>
<given-names>L.V.</given-names>
</name>
<name>
<surname>Ahmadian</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Salter</surname>
<given-names>M.W.</given-names>
</name>
</person-group>
<article-title>Glycine binding primes NMDA receptor internalization</article-title>
<source/>Nature
          <year>2003</year>
<volume>422</volume>
<fpage>302</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="doi">10.1038/nature01497</pub-id>
<pub-id pub-id-type="pmid">12646920</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-21-01538">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Papouin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ladépêche</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Langlais</surname>
<given-names>V.C.</given-names>
</name>
<name>
<surname>Bouchet</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dulong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mothet</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Sacchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pollegioni</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses</article-title>
<source/>Elife
          <year>2017</year>
<volume>6</volume>
<fpage>e25492</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.25492</pub-id>
<pub-id pub-id-type="pmid">28598327</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-21-01538">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayford</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kandel</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>O’Dell</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>CaMKII regulates the frequency-response function of hippocampal synapses for the production of both LTD and LTP</article-title>
<source/>Cell
          <year>1995</year>
<volume>81</volume>
<fpage>891</fpage>
<lpage>904</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(95)90009-8</pub-id>
<pub-id pub-id-type="pmid">7781066</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-21-01538">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scanziani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Malenka</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Nicoll</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Role of intercellular interactions in heterosynaptic long-term depression</article-title>
<source/>Nature
          <year>1996</year>
<volume>380</volume>
<fpage>446</fpage>
<lpage>450</lpage>
<pub-id pub-id-type="doi">10.1038/380446a0</pub-id>
<pub-id pub-id-type="pmid">8602244</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-21-01538">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Jahr</surname>
<given-names>C.E.</given-names>
</name>
</person-group>
<article-title>Postsynaptic, not presynaptic NMDA receptors are required for spike-timing-dependent LTD induction</article-title>
<source/>Nat. Neurosci.
          <year>2016</year>
<volume>19</volume>
<fpage>1218</fpage>
<lpage>1224</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4343</pub-id>
<pub-id pub-id-type="pmid">27399842</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-21-01538">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nabavi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kessels</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Alfonso</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aow</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>4027</fpage>
<lpage>4032</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1219454110</pub-id>
<pub-id pub-id-type="pmid">23431133</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-21-01538">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dore</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Aow</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Agonist binding to the NMDA receptor drives movement of its cytoplasmic domain without ion flow</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2015</year>
<volume>112</volume>
<fpage>14705</fpage>
<lpage>14710</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1520023112</pub-id>
<pub-id pub-id-type="pmid">26553997</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-21-01538">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monyer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Burnashev</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Laurie</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Sakmann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Seeburg</surname>
<given-names>P.H.</given-names>
</name>
</person-group>
<article-title>Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</article-title>
<source/>Neuron
          <year>1994</year>
<volume>12</volume>
<fpage>529</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1016/0896-6273(94)90210-0</pub-id>
<pub-id pub-id-type="pmid">7512349</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-21-01538">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akazawa</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shigemoto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bessho</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats</article-title>
<source/>J. Comp. Neurol.
          <year>1994</year>
<volume>347</volume>
<fpage>150</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1002/cne.903470112</pub-id>
<pub-id pub-id-type="pmid">7798379</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-21-01538">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paoletti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bellone</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>NMDA receptor subunit diversity: Impact on receptor properties, synaptic plasticity and disease</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2013</year>
<volume>14</volume>
<fpage>383</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3504</pub-id>
<pub-id pub-id-type="pmid">23686171</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-21-01538">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.S.</given-names>
</name>
</person-group>
<article-title>NMDA receptor signaling: Death or survival?</article-title>
<source/>Front. Biol. (Beijing)
          <year>2011</year>
<volume>6</volume>
<fpage>468</fpage>
<lpage>476</lpage>
<pub-id pub-id-type="doi">10.1007/s11515-011-1187-6</pub-id>
<pub-id pub-id-type="pmid">23144645</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-21-01538">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cercato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vàzquez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kornisiuk</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Aquirre</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Colettis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Snitcofsky</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jerusalinski</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Baez</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>GluN1 and GluN2A NMDA Receptor Subunits Increase in the Hippocampus during Memory Consolidation in the Rat</article-title>
<source/>Front. Behav. Neurosci.
          <year>2017</year>
<volume>13</volume>
<fpage>242</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2016.00242</pub-id>
<pub-id pub-id-type="pmid">28133447</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-21-01538">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groc</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Heine</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cousins</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>Lounis</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cognet</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Choquet</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>NMDA receptor surface mobility depends on NR2A-2B subunits</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2006</year>
<volume>103</volume>
<fpage>18769</fpage>
<lpage>18774</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0605238103</pub-id>
<pub-id pub-id-type="pmid">17124177</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-21-01538">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Retchless</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction</article-title>
<source/>Nat. Neurosci.
          <year>2012</year>
<volume>15</volume>
<fpage>406-S2</fpage>
<pub-id pub-id-type="doi">10.1038/nn.3025</pub-id>
<pub-id pub-id-type="pmid">22246434</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-21-01538">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Subtype-dependence of NMDA receptor channel open probability</article-title>
<source/>J. Neurosci.
          <year>1999</year>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-16-06844.1999</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-21-01538">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flint</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Maisch</surname>
<given-names>U.S.</given-names>
</name>
<name>
<surname>Weishaupt</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Kriegstein</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Monyer</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex</article-title>
<source/>J. Neurosci.
          <year>1997</year>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-07-02469.1997</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-21-01538">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krupp</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Vissel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>G.L.</given-names>
</name>
</person-group>
<article-title>Calcium-dependent inactivation of recombinant N-methyl-D-aspartate receptors is NR2 subunit specific</article-title>
<source/>Mol. Pharmacol.
          <year>1996</year>
<volume>50</volume>
<fpage>1680</fpage>
<lpage>1688</lpage>
<pub-id pub-id-type="pmid">8967993</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-21-01538">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vicini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Grayson</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Functional and pharmacological differences between recombinant N- methyl-D-aspartate receptors</article-title>
<source/>J. Neurophysiol.
          <year>1998</year>
<volume>79</volume>
<fpage>555</fpage>
<lpage>566</lpage>
<pub-id pub-id-type="doi">10.1152/jn.1998.79.2.555</pub-id>
<pub-id pub-id-type="pmid">9463421</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-21-01538">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bell</surname>
<given-names>K.F.S.</given-names>
</name>
<name>
<surname>Hardingham</surname>
<given-names>G.E.</given-names>
</name>
</person-group>
<article-title>The influence of synaptic activity on neuronal health</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2011</year>
<volume>21</volume>
<fpage>299</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2011.01.002</pub-id>
<pub-id pub-id-type="pmid">21292474</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-21-01538">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardingham</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>NMDA receptor C-terminal signaling in development, plasticity, and disease</article-title>
<source/>F1000Research
          <year>2019</year>
<volume>8</volume>
<fpage>1547</fpage>
<pub-id pub-id-type="doi">10.12688/f1000research.19925.1</pub-id>
<pub-id pub-id-type="pmid">31508206</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-21-01538">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>The Functional and Molecular Properties, Physiological Functions, and Pathophysiological Roles of GluN2A in the Central Nervous System</article-title>
<source/>Mol. Neurobiol.
          <year>2017</year>
<volume>54</volume>
<fpage>1008</fpage>
<lpage>1021</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-016-9715-7</pub-id>
<pub-id pub-id-type="pmid">26797520</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-21-01538">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baez</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Cercato</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Jerusalinsky</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>NMDA receptor subunits change after synaptic plasticity induction and learning and memory acquisition</article-title>
<source/>Neural Plast.
          <year>2018</year>
<volume>2018</volume>
<pub-id pub-id-type="doi">10.1155/2018/5093048</pub-id>
<pub-id pub-id-type="pmid">29706992</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-21-01538">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Di Luca</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Targeting glutamatergic synapses in Parkinson’s disease</article-title>
<source/>Curr. Opin. Pharmacol.
          <year>2015</year>
<volume>20</volume>
<fpage>24</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1016/j.coph.2014.10.011</pub-id>
<pub-id pub-id-type="pmid">25462288</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-21-01538">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Ascher</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Glycine potentiates the NMDA response in cultured mouse brain neurons</article-title>
<source/>Nature
          <year>1987</year>
<volume>325</volume>
<fpage>529</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="doi">10.1038/325529a0</pub-id>
<pub-id pub-id-type="pmid">2433595</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-21-01538">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christine</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons</article-title>
<source/>J. Neurosci.
          <year>1990</year>
<volume>10</volume>
<fpage>108</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.10-01-00108.1990</pub-id>
<pub-id pub-id-type="pmid">1688929</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-21-01538">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Legendre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>G.L.</given-names>
</name>
</person-group>
<article-title>The inhibition of single N-methyl-D-aspartate-activated channels by zinc ions on cultured rat neurones</article-title>
<source/>J. Physiol.
          <year>1990</year>
<volume>429</volume>
<fpage>429</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.1990.sp018266</pub-id>
<pub-id pub-id-type="pmid">1703572</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-21-01538">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fayyazuddin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Villarroel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Le Goff</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lerma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Neyton</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors</article-title>
<source/>Neuron
          <year>2000</year>
<volume>25</volume>
<fpage>683</fpage>
<lpage>694</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)81070-3</pub-id>
<pub-id pub-id-type="pmid">10774735</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-21-01538">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Moshaver</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition</article-title>
<source/>Mol. Pharmacol.
          <year>1997</year>
<volume>51</volume>
<fpage>1015</fpage>
<lpage>1023</lpage>
<pub-id pub-id-type="doi">10.1124/mol.51.6.1015</pub-id>
<pub-id pub-id-type="pmid">9187268</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-21-01538">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Vyklicky</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The action of zinc on synaptic transmission and neuronal excitability in cultures of mouse hippocampus</article-title>
<source/>J. Physiol.
          <year>1989</year>
<volume>415</volume>
<fpage>315</fpage>
<lpage>365</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.1989.sp017725</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-21-01538">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paoletti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ascher</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Neyton</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>High-affinity zinc inhibition of NMDA NR1-NR2A receptors</article-title>
<source/>J. Neurosci.
          <year>1997</year>
<volume>17</volume>
<fpage>5711</fpage>
<lpage>5725</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-15-05711.1997</pub-id>
<pub-id pub-id-type="pmid">9221770</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-21-01538">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Mason-Parker</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Abraham</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Tate</surname>
<given-names>W.P.</given-names>
</name>
</person-group>
<article-title>Biphasic changes in the levels of N-methyl-D-aspartate receptor-2 subunits correlate with the induction and persistence of long-term potentiation</article-title>
<source/>Mol. Brain Res.
          <year>1998</year>
<volume>60</volume>
<fpage>21</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1016/S0169-328X(98)00154-5</pub-id>
<pub-id pub-id-type="pmid">9748484</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-21-01538">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Traynelis</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Cull-Candy</surname>
<given-names>S.G.</given-names>
</name>
</person-group>
<article-title>Pharmacological properties and H+ sensitivity of excitatory amino acid receptor channels in rat cerebellar granule neurones</article-title>
<source/>J. Physiol.
          <year>1991</year>
<volume>443</volume>
<fpage>727</fpage>
<lpage>763</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.1991.sp018453</pub-id>
<pub-id pub-id-type="pmid">1688028</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-21-01538">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Traynelis</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Cull-Candy</surname>
<given-names>S.G.</given-names>
</name>
</person-group>
<article-title>Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons</article-title>
<source/>Nature
          <year>1990</year>
<volume>345</volume>
<fpage>347</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="doi">10.1038/345347a0</pub-id>
<pub-id pub-id-type="pmid">1692970</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-21-01538">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velíšek</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dreier</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Moshé</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Lowering of extracellular pH suppresses low-Mg2+-induces seizures in combined entorhinal cortex-hippocampal slices</article-title>
<source/>Exp. Brain Res.
          <year>1994</year>
<volume>101</volume>
<fpage>44</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1007/BF00243215</pub-id>
<pub-id pub-id-type="pmid">7843301</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-21-01538">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banke</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Dravid</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Traynelis</surname>
<given-names>S.F.</given-names>
</name>
</person-group>
<article-title>Protons trap NR1/NR2B NMDA receptors in a nonconducting state</article-title>
<source/>J. Neurosci.
          <year>2005</year>
<volume>25</volume>
<fpage>42</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3154-04.2005</pub-id>
<pub-id pub-id-type="pmid">15634765</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-21-01538">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural Basis of the Proton Sensitivity of Human GluN1-GluN2A NMDA Receptors</article-title>
<source/>Cell Rep.
          <year>2018</year>
<volume>25</volume>
<fpage>3582</fpage>
<lpage>3590</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2018.11.071</pub-id>
<pub-id pub-id-type="pmid">30590034</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-21-01538">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serraz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Grand</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Paoletti</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations</article-title>
<source/>Neuropharmacology
          <year>2016</year>
<volume>109</volume>
<fpage>196</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2016.06.008</pub-id>
<pub-id pub-id-type="pmid">27288002</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-21-01538">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.M.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.G.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>An endoplasmic reticulum retention signal located in the extracellular amino-terminal domain of the NR2A subunit of N-methyl-D-aspartate receptors</article-title>
<source/>J. Biol. Chem.
          <year>2009</year>
<volume>284</volume>
<fpage>20285</fpage>
<lpage>20298</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M109.004960</pub-id>
<pub-id pub-id-type="pmid">19487695</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-21-01538">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wollmuth</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Kuner</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sakmann</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg 2+</article-title>
<source/>J. Physiol.
          <year>1998</year>
<volume>506</volume>
<fpage>13</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7793.1998.013bx.x</pub-id>
<pub-id pub-id-type="pmid">9481670</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-21-01538">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marwick</surname>
<given-names>K.F.M.</given-names>
</name>
<name>
<surname>Skehel</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Hardingham</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Wyllie</surname>
<given-names>D.J.A.</given-names>
</name>
</person-group>
<article-title>The human NMDA receptor GluN2AN615K variant influences channel blocker potency</article-title>
<source/>Pharmacol. Res. Perspect.
          <year>2019</year>
<volume>7</volume>
<fpage>e00495</fpage>
<pub-id pub-id-type="doi">10.1002/prp2.495</pub-id>
<pub-id pub-id-type="pmid">31249692</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-21-01538">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Endele</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rosenberger</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Geider</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Popp</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tamer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stefanova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Milh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kortüm</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fritsch</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pientka</surname>
<given-names>F.K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes</article-title>
<source/>Nat. Genet.
          <year>2010</year>
<volume>42</volume>
<fpage>1021</fpage>
<lpage>1026</lpage>
<pub-id pub-id-type="doi">10.1038/ng.677</pub-id>
<pub-id pub-id-type="pmid">20890276</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-21-01538">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Traynelis</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Wollmuth</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>McBain</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Menniti</surname>
<given-names>F.S.</given-names>
</name>
<name>
<surname>Vance</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Ogden</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Dingledine</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Glutamate receptor ion channels: Structure, regulation, and function</article-title>
<source/>Pharmacol. Rev.
          <year>2010</year>
<volume>62</volume>
<fpage>405</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="doi">10.1124/pr.109.002451</pub-id>
<pub-id pub-id-type="pmid">20716669</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-21-01538">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>The differences between GluN2A and GluN2B signaling in the brain</article-title>
<source/>J. Neurosci. Res.
          <year>2018</year>
<volume>96</volume>
<fpage>1430</fpage>
<lpage>1433</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.24251</pub-id>
<pub-id pub-id-type="pmid">29682799</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-21-01538">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hawkins</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Prybylowski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Moussan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>Wenthold</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Export from the endoplasmic reticulum of assembled N-methyl-D-aspartic acid receptors is controlled by a motif in the C terminus of the NR2 subunit</article-title>
<source/>J. Biol. Chem.
          <year>2004</year>
<volume>279</volume>
<fpage>28903</fpage>
<lpage>28910</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M402599200</pub-id>
<pub-id pub-id-type="pmid">15102836</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-21-01538">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>K.W.</given-names>
</name>
</person-group>
<article-title>Regulation of NMDA receptors by phosphorylation</article-title>
<source/>Neuropharmacology
          <year>2007</year>
<volume>53</volume>
<fpage>362</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2007.05.018</pub-id>
<pub-id pub-id-type="pmid">17644144</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-21-01538">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snyder</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Philpot</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fallon</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Internalization of ionotropic glutamate receptors in response to mGluR activation</article-title>
<source/>Nat. Neurosci.
          <year>2001</year>
<volume>4</volume>
<fpage>1079</fpage>
<lpage>1085</lpage>
<pub-id pub-id-type="doi">10.1038/nn746</pub-id>
<pub-id pub-id-type="pmid">11687813</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-21-01538">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Otsu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Differential regulation of synaptic and extrasynaptic NMDA receptors</article-title>
<source/>Nat. Neurosci.
          <year>2002</year>
<volume>5</volume>
<fpage>833</fpage>
<lpage>834</lpage>
<pub-id pub-id-type="doi">10.1038/nn912</pub-id>
<pub-id pub-id-type="pmid">12195433</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-21-01538">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero-Hernandez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Novel mode of antagonist binding in NMDA receptors revealed by the crystal structure of the GluN1-GluN2A ligand-binding domain complexed to NVP-AAM077</article-title>
<source/>Mol. Pharmacol.
          <year>2017</year>
<volume>92</volume>
<fpage>22</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1124/mol.116.107912</pub-id>
<pub-id pub-id-type="pmid">28468946</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-21-01538">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frizelle</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wyllie</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1NR2A and NR1NR2B N-methyl-D-aspartate receptors Im</article-title>
<source/>Mol. Pharmacol.
          <year>2006</year>
<volume>70</volume>
<fpage>1022</fpage>
<lpage>1032</lpage>
<pub-id pub-id-type="doi">10.1124/mol.106.024042</pub-id>
<pub-id pub-id-type="pmid">16778008</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-21-01538">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schreiber</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Westphälinger</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Schepmann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Strutz-Seebohm</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Seebohm</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wünsch</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Systematic variation of the benzoylhydrazine moiety of the GluN2A selective NMDA receptor antagonist TCN-201</article-title>
<source/>Eur. J. Med. Chem.
          <year>2018</year>
<volume>158</volume>
<fpage>259</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmech.2018.09.006</pub-id>
<pub-id pub-id-type="pmid">30218911</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-21-01538">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mou</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Dorsett</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Volkmann</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Menniti</surname>
<given-names>F.S.</given-names>
</name>
<name>
<surname>Sprang</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>K.B.</given-names>
</name>
</person-group>
<article-title>Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors</article-title>
<source/>Neuron
          <year>2016</year>
<volume>91</volume>
<fpage>1316</fpage>
<lpage>1329</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.08.014</pub-id>
<pub-id pub-id-type="pmid">27618671</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-21-01538">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hackos</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Lupardus</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Grand</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Reynen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gustafson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wallweber</surname>
<given-names>H.J.A.</given-names>
</name>
<name>
<surname>Volgraf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sellers</surname>
<given-names>B.D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function</article-title>
<source/>Neuron
          <year>2016</year>
<volume>89</volume>
<fpage>983</fpage>
<lpage>999</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.01.016</pub-id>
<pub-id pub-id-type="pmid">26875626</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-21-01538">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volgraf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sellers</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ly</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Villemure</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pastor</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs) Tuning Deactivation Kinetics via Structure-Based Design</article-title>
<source/>J. Med. Chem.
          <year>2016</year>
<volume>59</volume>
<fpage>2760</fpage>
<lpage>2779</lpage>
<pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b02010</pub-id>
<pub-id pub-id-type="pmid">26919761</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-21-01538">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villemure</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Volgraf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ly</surname>
<given-names>C.Q.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>P.W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GluN2A-selective pyridopyrimidinone series of nmdar positive allosteric modulators with an improved in vivo profile</article-title>
<source/>ACS Med. Chem. Lett.
          <year>2016</year>
<volume>8</volume>
<fpage>84</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1021/acsmedchemlett.6b00388</pub-id>
<pub-id pub-id-type="pmid">28105280</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-21-01538">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Hell</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102</article-title>
<source/>J. Biol. Chem.
          <year>2002</year>
<volume>277</volume>
<fpage>21697</fpage>
<lpage>21711</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112339200</pub-id>
<pub-id pub-id-type="pmid">11937501</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-21-01538">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kornau</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Schenker</surname>
<given-names>L.T.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Seeburg</surname>
<given-names>P.H.</given-names>
</name>
</person-group>
<article-title>Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95</article-title>
<source/>Science (80-. )
          <year>1995</year>
<pub-id pub-id-type="doi">10.1126/science.7569905</pub-id>
</element-citation>
</ref>
<ref id="B69-ijms-21-01538">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howard</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Elias</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Elias</surname>
<given-names>L.A.B.</given-names>
</name>
<name>
<surname>Swat</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Nicoll</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>The role of SAP97 in synaptic glutamate receptor dynamics</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>3805</fpage>
<lpage>3810</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0914422107</pub-id>
<pub-id pub-id-type="pmid">20133708</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-21-01538">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sala</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>PDZ Domains and the Organization of Supramolecular Complexes</article-title>
<source/>Annu. Rev. Neurosci.
          <year>2001</year>
<volume>24</volume>
<fpage>1</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.neuro.24.1.1</pub-id>
<pub-id pub-id-type="pmid">11283303</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-21-01538">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Carta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eberini</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pelucchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marcello</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Genazzani</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Racca</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mulle</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Di Luca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex</article-title>
<source/>Nat. Commun.
          <year>2015</year>
<volume>6</volume>
<fpage>10181</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms10181</pub-id>
<pub-id pub-id-type="pmid">26679993</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-21-01538">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>FRMPD2: A novel GluN2A-interacting scaffold protein in synaptic excitatory transmission</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2018</year>
</element-citation>
</ref>
<ref id="B73-ijms-21-01538">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piguel</surname>
<given-names>N.H.</given-names>
</name>
<name>
<surname>Fievre</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Blanc</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Carta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moreau</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Moutin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pinheiro</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ezan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lasvaux</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Scribble1/AP2 complex coordinates NMDA receptor endocytic recycling</article-title>
<source/>Cell Rep.
          <year>2014</year>
<volume>9</volume>
<fpage>712</fpage>
<lpage>727</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2014.09.017</pub-id>
<pub-id pub-id-type="pmid">25310985</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-21-01538">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panayotis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Karpova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kreutz</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Fainzilber</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Macromolecular transport in synapse to nucleus communication</article-title>
<source/>Trends Neurosci.
          <year>2015</year>
<volume>38</volume>
<fpage>108</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2014.12.001</pub-id>
<pub-id pub-id-type="pmid">25534890</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-21-01538">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marcello</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Di Luca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Synapse-to-nucleus communication: From developmental disorders to Alzheimer’s disease</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2018</year>
<volume>48</volume>
<fpage>160</fpage>
<lpage>166</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2017.12.017</pub-id>
<pub-id pub-id-type="pmid">29316492</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-21-01538">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinamarca</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Guzzetti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Karpova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mitro</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Musardo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mellone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marcello</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stanic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Samaddar</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ring finger protein 10 is a novel synaptonuclear messenger encoding activation of NMDA receptors in hippocampus</article-title>
<source/>Elife
          <year>2016</year>
<volume>5</volume>
<fpage>e12430</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.12430</pub-id>
<pub-id pub-id-type="pmid">26977767</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-21-01538">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jordan</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Fernholz</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Khatri</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ziff</surname>
<given-names>E.B.</given-names>
</name>
</person-group>
<article-title>Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers and protein synthesis in neurons</article-title>
<source/>Nat. Neurosci.
          <year>2007</year>
<pub-id pub-id-type="doi">10.1038/nn1867</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-21-01538">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ark</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Parra-Bueno</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yasuda</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Long-distance integration of nuclear ERK signaling triggered by activation of a few dendritic spines</article-title>
<source/>Science (80-. )
          <year>2013</year>
<pub-id pub-id-type="doi">10.1126/science.1245622</pub-id>
</element-citation>
</ref>
<ref id="B79-ijms-21-01538">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schrama</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kamal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gispen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cattabeni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Di Luca</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Hippocampal synaptic plasticity involves competition between Ca2+calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptor</article-title>
<source/>J. Neurosci.
          <year>2001</year>
<volume>21</volume>
<fpage>1501</fpage>
<lpage>1509</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-05-01501.2001</pub-id>
<pub-id pub-id-type="pmid">11222640</pub-id>
</element-citation>
</ref>
<ref id="B80-ijms-21-01538">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bellone</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cattabeni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Di Luca</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Protein Kinase C Activation Modulates α-Calmodulin Kinase II Binding to NR2A Subunit of N-Methyl-<sc>d</sc>-Aspartate Receptor Complex</article-title>
<source/>J. Biol. Chem.
          <year>2001</year>
<volume>273</volume>
<fpage>20689</fpage>
<lpage>20692</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M009922200</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-21-01538">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strack</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Colbran</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Autophosphorylation-dependent targeting of calcium calmodulin-dependent protein kinase II by the NR2B subunit of the N-methyl-<sc>d</sc>-aspartate receptor</article-title>
<source/>J. Biol. Chem.
          <year>1998</year>
<volume>273</volume>
<fpage>20689</fpage>
<lpage>20692</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.33.20689</pub-id>
<pub-id pub-id-type="pmid">9694809</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-21-01538">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayer</surname>
<given-names>K.U.</given-names>
</name>
<name>
<surname>Schulman</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Regulation of signal transduction by protein targeting: The case for CaMKII</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2001</year>
<volume>289</volume>
<fpage>917</fpage>
<lpage>923</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.2001.6063</pub-id>
<pub-id pub-id-type="pmid">11741277</pub-id>
</element-citation>
</ref>
<ref id="B83-ijms-21-01538">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braun</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Schulman</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The Multifunctional Calcium/Calmodulin-Dependent Protein Kinase: From Form to Function</article-title>
<source/>Annu. Rev. Physiol.
          <year>1995</year>
<volume>57</volume>
<fpage>417</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.ph.57.030195.002221</pub-id>
<pub-id pub-id-type="pmid">7778873</pub-id>
</element-citation>
</ref>
<ref id="B84-ijms-21-01538">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>M.B.</given-names>
</name>
</person-group>
<article-title>Regulation of brain Type II Ca2+ calmodulin-dependent protein kinase by autophosphorylation: A Ca2+-triggered molecular switch</article-title>
<source/>Cell
          <year>1986</year>
<volume>44</volume>
<fpage>861</fpage>
<lpage>870</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(86)90008-5</pub-id>
<pub-id pub-id-type="pmid">3006921</pub-id>
</element-citation>
</ref>
<ref id="B85-ijms-21-01538">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colbran</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Calcium/calmodulin-dependent protein kinase II and synaptic plasticity</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2004</year>
<volume>14</volume>
<fpage>318</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2004.05.008</pub-id>
<pub-id pub-id-type="pmid">15194112</pub-id>
</element-citation>
</ref>
<ref id="B86-ijms-21-01538">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schrama</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Van Dalen</surname>
<given-names>J.J.W.</given-names>
</name>
<name>
<surname>Gispen</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Cattabeni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Di Luca</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>αCaMKII binding to the C-terminal tail of NMDA receptor subunit NR2A and its modulation by autophosphorylation</article-title>
<source/>FEBS Lett.
          <year>1999</year>
<volume>456</volume>
<fpage>394</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-5793(99)00985-0</pub-id>
<pub-id pub-id-type="pmid">10462051</pub-id>
</element-citation>
</ref>
<ref id="B87-ijms-21-01538">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Y.P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.M.</given-names>
</name>
</person-group>
<article-title>Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors</article-title>
<source/>Nat. Neurosci.
          <year>2003</year>
<volume>6</volume>
<fpage>1039</fpage>
<lpage>1047</lpage>
<pub-id pub-id-type="doi">10.1038/nn1119</pub-id>
<pub-id pub-id-type="pmid">14502288</pub-id>
</element-citation>
</ref>
<ref id="B88-ijms-21-01538">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Vinade</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kulkarni</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>R.O.</given-names>
</name>
<name>
<surname>Pant</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Regulation of NMDA receptors by cyclin-dependent kinase-5</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2001</year>
<volume>98</volume>
<fpage>12742</fpage>
<lpage>12747</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.211428098</pub-id>
<pub-id pub-id-type="pmid">11675505</pub-id>
</element-citation>
</ref>
<ref id="B89-ijms-21-01538">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hisatsune</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Umemori</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mishina</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Phosphorylation-dependent interaction of the N-methyl-D-aspartate receptor ε2 subunit with phosphatidylinositol 3-kinase</article-title>
<source/>Genes to Cells
          <year>1999</year>
<volume>4</volume>
<fpage>657</fpage>
<lpage>666</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2443.1999.00287.x</pub-id>
<pub-id pub-id-type="pmid">10620012</pub-id>
</element-citation>
</ref>
<ref id="B90-ijms-21-01538">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>F.J.S.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vukusic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chéry</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Niznik</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor</article-title>
<source/>Cell
          <year>2002</year>
<volume>111</volume>
<fpage>219</fpage>
<lpage>230</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(02)00962-5</pub-id>
<pub-id pub-id-type="pmid">12408866</pub-id>
</element-citation>
</ref>
<ref id="B91-ijms-21-01538">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elagabani</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Brisevac</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kintscher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pohle</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Köhr</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kornau</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Subunit-selective N-Methyl-D-aspartate (NMDA) receptor signaling through brefeldin a-resistant arf guanine nucleotide exchange factors BRAG1 and BRAG2 during synapse maturation</article-title>
<source/>J. Biol. Chem.
          <year>2016</year>
<volume>291</volume>
<fpage>9105</fpage>
<lpage>9118</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M115.691717</pub-id>
<pub-id pub-id-type="pmid">26884337</pub-id>
</element-citation>
</ref>
<ref id="B92-ijms-21-01538">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakagami</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sanda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fukaya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sukegawa</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yanagisawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fukunaga</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>IQ-ArfGEF/BRAG1 is a guanine nucleotide exchange factor for Arf6 that interacts with PSD-95 at postsynaptic density of excitatory synapses</article-title>
<source/>Neurosci. Res.
          <year>2008</year>
<volume>60</volume>
<fpage>199</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1016/j.neures.2007.10.013</pub-id>
<pub-id pub-id-type="pmid">18164504</pub-id>
</element-citation>
</ref>
<ref id="B93-ijms-21-01538">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hartley</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Feig</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Distinct roles for Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and Ras-GRF2 in the induction of long-term potentiation and long-term depression</article-title>
<source/>J. Neurosci.
          <year>2006</year>
<volume>26</volume>
<fpage>1721</fpage>
<lpage>1729</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3990-05.2006</pub-id>
<pub-id pub-id-type="pmid">16467520</pub-id>
</element-citation>
</ref>
<ref id="B94-ijms-21-01538">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gotoh</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Feig</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB</article-title>
<source/>EMBO J.
          <year>2004</year>
<volume>23</volume>
<fpage>1567</fpage>
<lpage>1575</lpage>
<pub-id pub-id-type="doi">10.1038/sj.emboj.7600151</pub-id>
<pub-id pub-id-type="pmid">15029245</pub-id>
</element-citation>
</ref>
<ref id="B95-ijms-21-01538">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fam</surname>
<given-names>N.P.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>W.T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Cloning and characterization of Ras-GRF2, a novel guanine nucleotide exchange factor for Ras</article-title>
<source/>Mol. Cell. Biol.
          <year>1997</year>
<volume>17</volume>
<fpage>1396</fpage>
<lpage>1406</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.17.3.1396</pub-id>
<pub-id pub-id-type="pmid">9032266</pub-id>
</element-citation>
</ref>
<ref id="B96-ijms-21-01538">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Farnsworth</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Neel</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Feig</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for Ras p21</article-title>
<source/>Nature
          <year>1992</year>
<volume>358</volume>
<fpage>351</fpage>
<lpage>354</lpage>
<pub-id pub-id-type="doi">10.1038/358351a0</pub-id>
<pub-id pub-id-type="pmid">1379346</pub-id>
</element-citation>
</ref>
<ref id="B97-ijms-21-01538">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>W.T.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>De Hoog</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Fam</surname>
<given-names>N.P.</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>The exchange factor Ras-GRF2 activates Ras-dependent and Rac-dependent mitogen-activated protein kinase pathways</article-title>
<source/>Curr. Biol.
          <year>1998</year>
<volume>8</volume>
<fpage>935</fpage>
<lpage>938</lpage>
<pub-id pub-id-type="doi">10.1016/S0960-9822(07)00376-4</pub-id>
<pub-id pub-id-type="pmid">9707409</pub-id>
</element-citation>
</ref>
<ref id="B98-ijms-21-01538">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Innocenti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zippel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Brambilla</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sturani</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>CDC25(Mm)/Ras-GRF1 regulates both Ras and Rac signaling pathways</article-title>
<source/>FEBS Lett.
          <year>1999</year>
<volume>460</volume>
<fpage>357</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-5793(99)01374-5</pub-id>
<pub-id pub-id-type="pmid">10544264</pub-id>
</element-citation>
</ref>
<ref id="B99-ijms-21-01538">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sacks</surname>
<given-names>D.B.</given-names>
</name>
</person-group>
<article-title>IQGAP1 integrates Ca2+calmodulin and B-Raf signaling</article-title>
<source/>J. Biol. Chem.
          <year>2008</year>
<volume>283</volume>
<fpage>22972</fpage>
<lpage>22982</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M804626200</pub-id>
<pub-id pub-id-type="pmid">18567582</pub-id>
</element-citation>
</ref>
<ref id="B100-ijms-21-01538">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reiner</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Sapoznik</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sapir</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Lissencephaly 1 linking to multiple diseases: Mental retardation, neurodegeneration, schizophrenia, male sterility, and more</article-title>
<source/>NeuroMolecular Med.
          <year>2006</year>
<volume>8</volume>
<fpage>547</fpage>
<lpage>565</lpage>
<pub-id pub-id-type="doi">10.1385/NMM:8:4:547</pub-id>
<pub-id pub-id-type="pmid">17028375</pub-id>
</element-citation>
</ref>
<ref id="B101-ijms-21-01538">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kholmanskikh</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Koeller</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Wynshaw-Boris</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Letourneau</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Calcium-dependent interaction of Lis1 with IQGAP1 and Cdc42 promotes neuronal motility</article-title>
<source/>Nat. Neurosci.
          <year>2006</year>
<volume>9</volume>
<fpage>50</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1038/nn1619</pub-id>
<pub-id pub-id-type="pmid">16369480</pub-id>
</element-citation>
</ref>
<ref id="B102-ijms-21-01538">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Futai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Feliu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Constitutively active Rap2 transgenic mice display fewer dendritic spines, reduced extracellular signal-regulated kinase signaling, enhanced long-term depression, and impaired spatial learning and fear extinction</article-title>
<source/>J. Neurosci.
          <year>2008</year>
<volume>28</volume>
<fpage>8178</fpage>
<lpage>8188</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1944-08.2008</pub-id>
<pub-id pub-id-type="pmid">18701680</pub-id>
</element-citation>
</ref>
<ref id="B103-ijms-21-01538">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajaj</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hau</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gafken</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Schimerlik</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Ishmael</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Identification of an atypical calcium-dependent calmodulin binding site on the C-terminal domain of GluN2A</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2014</year>
<volume>44</volume>
<fpage>588</fpage>
<lpage>594</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2014.01.111</pub-id>
<pub-id pub-id-type="pmid">24491550</pub-id>
</element-citation>
</ref>
<ref id="B104-ijms-21-01538">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Groth</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Emery</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hoedt</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Neubert</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Tsien</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>γcaMKII shuttles Ca2+/CaM to the nucleus to trigger CREB phosphorylation and gene expression</article-title>
<source/>Cell
          <year>2014</year>
<volume>159</volume>
<fpage>281</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.09.019</pub-id>
<pub-id pub-id-type="pmid">25303525</pub-id>
</element-citation>
</ref>
<ref id="B105-ijms-21-01538">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Suutari</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tirko</surname>
<given-names>N.N.</given-names>
</name>
<name>
<surname>Mandelberg</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Mullins</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Calmodulin shuttling mediates cytonuclear signaling to trigger experience-dependent transcription and memory</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.1038/s41467-018-04705-8</pub-id>
<pub-id pub-id-type="pmid">29934532</pub-id>
</element-citation>
</ref>
<ref id="B106-ijms-21-01538">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kuchibhotla</surname>
<given-names>K.V.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>B.O.</given-names>
</name>
<name>
<surname>Buzsáki</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Froemke</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Tsien</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>Excitation-Transcription Coupling in Parvalbumin-Positive Interneurons Employs a Novel CaM Kinase-Dependent Pathway Distinct from Excitatory Neurons</article-title>
<source/>Neuron
          <year>2016</year>
<volume>90</volume>
<fpage>292</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.03.001</pub-id>
<pub-id pub-id-type="pmid">27041500</pub-id>
</element-citation>
</ref>
<ref id="B107-ijms-21-01538">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.M.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X.Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Qiang</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y.L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activity-induced synaptic delivery of the GluN2A-containing NMDA receptor is dependent on endoplasmic reticulum chaperone Bip and involved in fear memory</article-title>
<source/>Cell Res.
          <year>2015</year>
<volume>25</volume>
<fpage>818</fpage>
<lpage>836</lpage>
<pub-id pub-id-type="doi">10.1038/cr.2015.75</pub-id>
<pub-id pub-id-type="pmid">26088419</pub-id>
</element-citation>
</ref>
<ref id="B108-ijms-21-01538">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malenka</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>LTP and LTD: An embarrassment of riches</article-title>
<source/>Neuron
          <year>2004</year>
<volume>44</volume>
<fpage>5</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2004.09.012</pub-id>
<pub-id pub-id-type="pmid">15450156</pub-id>
</element-citation>
</ref>
<ref id="B109-ijms-21-01538">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lujan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>T.Y.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>M.X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Man</surname>
<given-names>H.Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glycine potentiates AMPA receptor function through metabotropic activation of GluN2A-containing NMDA receptors</article-title>
<source/>Front. Mol. Neurosci.
          <year>2016</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.3389/fnmol.2016.00102</pub-id>
</element-citation>
</ref>
<ref id="B110-ijms-21-01538">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Pozza</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Lingenhoehl</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Auberson</surname>
<given-names>Y.P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.T.</given-names>
</name>
</person-group>
<article-title>Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity</article-title>
<source/>Science (80-. )
          <year>2004</year>
<volume>304</volume>
<fpage>1021</fpage>
<lpage>1024</lpage>
<pub-id pub-id-type="doi">10.1126/science.1096615</pub-id>
</element-citation>
</ref>
<ref id="B111-ijms-21-01538">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massey</surname>
<given-names>P.V.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Moult</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Auberson</surname>
<given-names>Y.P.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Molnar</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Collingridge</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Bashir</surname>
<given-names>Z.I.</given-names>
</name>
</person-group>
<article-title>Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression</article-title>
<source/>J. Neurosci.
          <year>2004</year>
<volume>24</volume>
<fpage>7821</fpage>
<lpage>7828</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1697-04.2004</pub-id>
<pub-id pub-id-type="pmid">15356193</pub-id>
</element-citation>
</ref>
<ref id="B112-ijms-21-01538">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>F.S.</given-names>
</name>
<name>
<surname>Abbas</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Wigström</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Role of NMDA receptor subtypes in different forms of NMDA-dependent synaptic plasticity</article-title>
<source/>BMC Neurosci.
          <year>2007</year>
<volume>8</volume>
<elocation-id>55</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2202-8-55</pub-id>
<pub-id pub-id-type="pmid">17655746</pub-id>
</element-citation>
</ref>
<ref id="B113-ijms-21-01538">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartlett</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Bannister</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Collett</surname>
<given-names>V.J.</given-names>
</name>
<name>
<surname>Dargan</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Massey</surname>
<given-names>P.V.</given-names>
</name>
<name>
<surname>Bortolotto</surname>
<given-names>Z.A.</given-names>
</name>
<name>
<surname>Fitzjohn</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Bashir</surname>
<given-names>Z.I.</given-names>
</name>
<name>
<surname>Collingridge</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Lodge</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus</article-title>
<source/>Neuropharmacology
          <year>2007</year>
<volume>52</volume>
<fpage>60</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2006.07.013</pub-id>
<pub-id pub-id-type="pmid">16904707</pub-id>
</element-citation>
</ref>
<ref id="B114-ijms-21-01538">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fox</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>K.I.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Christie</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo</article-title>
<source/>Hippocampus
          <year>2006</year>
<volume>16</volume>
<fpage>907</fpage>
<lpage>915</lpage>
<pub-id pub-id-type="doi">10.1002/hipo.20230</pub-id>
<pub-id pub-id-type="pmid">17024679</pub-id>
</element-citation>
</ref>
<ref id="B115-ijms-21-01538">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berberich</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Punnakkal</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pawlak</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Seeburg</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Hvalby</surname>
<given-names>Ø.</given-names>
</name>
<name>
<surname>Köhr</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation</article-title>
<source/>J. Neurosci.
          <year>2005</year>
<volume>25</volume>
<fpage>6907</fpage>
<lpage>6910</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1905-05.2005</pub-id>
<pub-id pub-id-type="pmid">16033900</pub-id>
</element-citation>
</ref>
<ref id="B116-ijms-21-01538">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Raffel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sprengel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Seeburg</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Rawlins</surname>
<given-names>J.N.P.</given-names>
</name>
<name>
<surname>Bannerman</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Paulsen</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Induction and expression of GluA1 (GluR-A)-independent LTP in the hippocampus</article-title>
<source/>Eur. J. Neurosci.
          <year>2009</year>
<volume>29</volume>
<fpage>1141</fpage>
<lpage>1152</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2009.06677.x</pub-id>
<pub-id pub-id-type="pmid">19302150</pub-id>
</element-citation>
</ref>
<ref id="B117-ijms-21-01538">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izumi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Auberson</surname>
<given-names>Y.P.</given-names>
</name>
<name>
<surname>Zorumski</surname>
<given-names>C.F.</given-names>
</name>
</person-group>
<article-title>Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors</article-title>
<source/>J. Neurosci.
          <year>2006</year>
<volume>26</volume>
<fpage>7181</fpage>
<lpage>7188</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1258-06.2006</pub-id>
<pub-id pub-id-type="pmid">16822975</pub-id>
</element-citation>
</ref>
<ref id="B118-ijms-21-01538">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pitcher</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Szilard</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Sertié</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kanisek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Clapcote</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Lipina</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kalia</surname>
<given-names>L.V.</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>McKerlie</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neto1 is a novel CUB-domain NMDA receptor-interacting protein required for synaptic plasticity and learning</article-title>
<source/>PLoS Biol.
          <year>2009</year>
<volume>7</volume>
<elocation-id>e41</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1000041</pub-id>
<pub-id pub-id-type="pmid">19243221</pub-id>
</element-citation>
</ref>
<ref id="B119-ijms-21-01538">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakimura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kutsuwada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Manabe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Takayama</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kushiya</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yagi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shinichi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ℰ1 subunit</article-title>
<source/>Nature
          <year>1995</year>
<volume>373</volume>
<fpage>151</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="doi">10.1038/373151a0</pub-id>
<pub-id pub-id-type="pmid">7816096</pub-id>
</element-citation>
</ref>
<ref id="B120-ijms-21-01538">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Manabe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sakimura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mishina</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Increased Thresholds for Long-Term Potentiation and Contextual Learning in Mice Lacking the NMDA-type Glutamate Receptor e1 Subunit</article-title>
<source/>J. Neurosci.
          <year>1998</year>
<volume>18</volume>
<fpage>6704</fpage>
<lpage>6712</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-17-06704.1998</pub-id>
<pub-id pub-id-type="pmid">9712642</pub-id>
</element-citation>
</ref>
<ref id="B121-ijms-21-01538">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Köhr</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Koester</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Mihaljevic</surname>
<given-names>A.L.A.</given-names>
</name>
<name>
<surname>Utvik</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Kvello</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>Seeburg</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Sprengel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hvalby</surname>
<given-names>Ø.</given-names>
</name>
</person-group>
<article-title>Intracellular Domains of NMDA Receptor Subtypes Are Determinants for Long-Term Potentiation Induction</article-title>
<source/>J. Neurosci.
          <year>2003</year>
<volume>23</volume>
<fpage>10791</fpage>
<lpage>10799</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-34-10791.2003</pub-id>
<pub-id pub-id-type="pmid">14645471</pub-id>
</element-citation>
</ref>
<ref id="B122-ijms-21-01538">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moody</surname>
<given-names>T.D.</given-names>
</name>
<name>
<surname>Watabe</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Indersmitten</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Komiyama</surname>
<given-names>N.H.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>S.G.N.</given-names>
</name>
<name>
<surname>O’Dell</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>β-adrenergic receptor activation rescues theta frequency stimulation-induced LTP deficits in mice expressing C-terminally truncated NMDA receptor GluN2A subunits</article-title>
<source/>Learn. Mem.
          <year>2011</year>
<volume>18</volume>
<fpage>118</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1101/lm.2045311</pub-id>
<pub-id pub-id-type="pmid">21257779</pub-id>
</element-citation>
</ref>
<ref id="B123-ijms-21-01538">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellone</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nicoll</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Rapid Bidirectional Switching of Synaptic NMDA Receptors</article-title>
<source/>Neuron
          <year>2007</year>
<volume>55</volume>
<fpage>779</fpage>
<lpage>785</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.07.035</pub-id>
<pub-id pub-id-type="pmid">17785184</pub-id>
</element-citation>
</ref>
<ref id="B124-ijms-21-01538">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grosshans</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Clayton</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Coultrap</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Browning</surname>
<given-names>M.D.</given-names>
</name>
</person-group>
<article-title>Analysis of glutamate receptor surface expression in acute hippocampal slices</article-title>
<source/>Sci. STKE
          <year>2002</year>
<volume>2002</volume>
<fpage>pI8</fpage>
<pub-id pub-id-type="doi">10.1126/stke.2002.137.pl8</pub-id>
<pub-id pub-id-type="pmid">12072555</pub-id>
</element-citation>
</ref>
<ref id="B125-ijms-21-01538">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franchini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Stanic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ponzoni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mellone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carrano</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Musardo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zianni</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Olivero</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Marcello</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pittaluga</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Linking NMDA Receptor Synaptic Retention to Synaptic Plasticity and Cognition</article-title>
<source/>iScience
          <year>2019</year>
<volume>19</volume>
<fpage>927</fpage>
<lpage>939</lpage>
<pub-id pub-id-type="doi">10.1016/j.isci.2019.08.036</pub-id>
<pub-id pub-id-type="pmid">31518901</pub-id>
</element-citation>
</ref>
<ref id="B126-ijms-21-01538">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baez</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Oberholzer</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Cercato</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Snitcofsky</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aguirre</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Jerusalinsky</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>NMDA Receptor Subunits in the Adult Rat Hippocampus Undergo Similar Changes after 5 Minutes in an Open Field and after LTP Induction</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e55244</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0055244</pub-id>
<pub-id pub-id-type="pmid">23383317</pub-id>
</element-citation>
</ref>
<ref id="B127-ijms-21-01538">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Udagawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Swanger</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Nalavadi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Zukin</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Bassell</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Bidirectional Control of mRNA Translation and Synaptic Plasticity by the Cytoplasmic Polyadenylation Complex</article-title>
<source/>Mol. Cell
          <year>2012</year>
<volume>47</volume>
<fpage>253</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2012.05.016</pub-id>
<pub-id pub-id-type="pmid">22727665</pub-id>
</element-citation>
</ref>
<ref id="B128-ijms-21-01538">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanger</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.A.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Bassell</surname>
<given-names>G.J.</given-names>
</name>
</person-group>
<article-title>Dendritic GluN2A synthesis mediates activity-induced NMDA receptor insertion</article-title>
<source/>J. Neurosci.
          <year>2013</year>
<volume>33</volume>
<fpage>8898</fpage>
<lpage>8908</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0289-13.2013</pub-id>
<pub-id pub-id-type="pmid">23678131</pub-id>
</element-citation>
</ref>
<ref id="B129-ijms-21-01538">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerkin</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>P.-M.</given-names>
</name>
<name>
<surname>Nauen</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>G.-Q.</given-names>
</name>
</person-group>
<article-title>Modular Competition Driven by NMDA Receptor Subtypes in Spike-Timing-Dependent Plasticity</article-title>
<source/>J. Neurophysiol.
          <year>2007</year>
<volume>97</volume>
<fpage>2851</fpage>
<lpage>2862</lpage>
<pub-id pub-id-type="doi">10.1152/jn.00860.2006</pub-id>
<pub-id pub-id-type="pmid">17267756</pub-id>
</element-citation>
</ref>
<ref id="B130-ijms-21-01538">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ge</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bagot</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Howland</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.T.</given-names>
</name>
</person-group>
<article-title>Hippocampal long-term depression is required for the consolidation of spatial memory</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>16697</fpage>
<lpage>16702</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1008200107</pub-id>
<pub-id pub-id-type="pmid">20823230</pub-id>
</element-citation>
</ref>
<ref id="B131-ijms-21-01538">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Longordo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kopp</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mishina</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luján</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lüthi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>NR2A at CA1 synapses is obligatory for the susceptibility of hippocampal plasticity to sleep loss</article-title>
<source/>J. Neurosci.
          <year>2009</year>
<volume>29</volume>
<fpage>9026</fpage>
<lpage>9041</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1215-09.2009</pub-id>
<pub-id pub-id-type="pmid">19605640</pub-id>
</element-citation>
</ref>
<ref id="B132-ijms-21-01538">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tsien</surname>
<given-names>J.Z.</given-names>
</name>
</person-group>
<article-title>Increased NR2A:NR2B ratio compresses long-term depression range and constrains long-term memory</article-title>
<source/>Sci. Rep.
          <year>2013</year>
<volume>3</volume>
<fpage>1036</fpage>
<pub-id pub-id-type="doi">10.1038/srep01036</pub-id>
<pub-id pub-id-type="pmid">23301157</pub-id>
</element-citation>
</ref>
<ref id="B133-ijms-21-01538">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>T.T.T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>21395</fpage>
<lpage>21400</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0910499106</pub-id>
<pub-id pub-id-type="pmid">19955431</pub-id>
</element-citation>
</ref>
<ref id="B134-ijms-21-01538">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lisman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schulman</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cline</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The molecular basis of CaMKII function in synaptic and behavioural memory</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2002</year>
<volume>3</volume>
<fpage>175</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1038/nrn753</pub-id>
<pub-id pub-id-type="pmid">11994750</pub-id>
</element-citation>
</ref>
<ref id="B135-ijms-21-01538">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrano</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Samaddar</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Brunialti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Franchini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Marcello</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ciana</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mauceri</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Di Luca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The Synaptonuclear Messenger RNF10 Acts as an Architect of Neuronal Morphology</article-title>
<source/>Mol. Neurobiol.
          <year>2019</year>
<volume>56</volume>
<fpage>7583</fpage>
<lpage>7593</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-019-1631-1</pub-id>
<pub-id pub-id-type="pmid">31069631</pub-id>
</element-citation>
</ref>
<ref id="B136-ijms-21-01538">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bliss</surname>
<given-names>T.V.P.</given-names>
</name>
<name>
<surname>Collingridge</surname>
<given-names>G.L.</given-names>
</name>
</person-group>
<article-title>A synaptic model of memory: Long-term potentiation in the hippocampus</article-title>
<source/>Nature
          <year>1993</year>
<volume>36</volume>
<fpage>31</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1038/361031a0</pub-id>
</element-citation>
</ref>
<ref id="B137-ijms-21-01538">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Grimwood</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>R.G.M.</given-names>
</name>
</person-group>
<article-title>Synaptic Plasticity and Memory: An Evaluation of the Hypothesis</article-title>
<source/>Annu. Rev. Neurosci.
          <year>2000</year>
<volume>23</volume>
<fpage>649</fpage>
<lpage>711</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.neuro.23.1.649</pub-id>
<pub-id pub-id-type="pmid">10845078</pub-id>
</element-citation>
</ref>
<ref id="B138-ijms-21-01538">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>R.G.M.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Baudry</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5</article-title>
<source/>Nature
          <year>1986</year>
<volume>319</volume>
<fpage>774</fpage>
<lpage>776</lpage>
<pub-id pub-id-type="doi">10.1038/319774a0</pub-id>
<pub-id pub-id-type="pmid">2869411</pub-id>
</element-citation>
</ref>
<ref id="B139-ijms-21-01538">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsien</surname>
<given-names>J.Z.</given-names>
</name>
<name>
<surname>Huerta</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Tonegawa</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory</article-title>
<source/>Cell
          <year>1996</year>
<volume>87</volume>
<fpage>1327</fpage>
<lpage>1338</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81827-9</pub-id>
<pub-id pub-id-type="pmid">8980238</pub-id>
</element-citation>
</ref>
<ref id="B140-ijms-21-01538">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bannerman</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Niewoehner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lyon</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Romberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sanderson</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Cottam</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sprengel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Seeburg</surname>
<given-names>P.H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory</article-title>
<source/>J. Neurosci.
          <year>2008</year>
<volume>28</volume>
<fpage>3623</fpage>
<lpage>3630</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3639-07.2008</pub-id>
<pub-id pub-id-type="pmid">18385321</pub-id>
</element-citation>
</ref>
<ref id="B141-ijms-21-01538">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.M.</given-names>
</name>
</person-group>
<article-title>Delay-dependent impairment of spatial working memory with inhibition of NR2B-containing NMDA receptors in hippocampal CA1 region of rats</article-title>
<source/>Mol. Brain
          <year>2013</year>
<pub-id pub-id-type="doi">10.1186/1756-6606-6-13</pub-id>
</element-citation>
</ref>
<ref id="B142-ijms-21-01538">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodfellow</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Abdulla</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Lindquist</surname>
<given-names>D.H.</given-names>
</name>
</person-group>
<article-title>Neonatal Ethanol Exposure Impairs Trace Fear Conditioning and Alters NMDA Receptor Subunit Expression in Adult Male and Female Rats</article-title>
<source/>Alcohol. Clin. Exp. Res.
          <year>2016</year>
<volume>40</volume>
<fpage>309</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="doi">10.1111/acer.12958</pub-id>
<pub-id pub-id-type="pmid">26842250</pub-id>
</element-citation>
</ref>
<ref id="B143-ijms-21-01538">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname>
<given-names>J.Q.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>B.X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hydrogen sulfide reverses aging-associated amygdalar synaptic plasticity and fear memory deficits in rats</article-title>
<source/>Front. Neurosci.
          <year>2018</year>
<volume>12</volume>
<pub-id pub-id-type="doi">10.3389/fnins.2018.00390</pub-id>
<pub-id pub-id-type="pmid">29930496</pub-id>
</element-citation>
</ref>
<ref id="B144-ijms-21-01538">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.W.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.G.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Knockdown of CLC-3 in the hippocampal CA1 impairs contextual fear memory</article-title>
<source/>Prog. Neuro-Psychopharmacology Biol. Psychiatry
          <year>2019</year>
<volume>89</volume>
<fpage>132</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2018.07.004</pub-id>
<pub-id pub-id-type="pmid">30025794</pub-id>
</element-citation>
</ref>
<ref id="B145-ijms-21-01538">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobs</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tsien</surname>
<given-names>J.Z.</given-names>
</name>
</person-group>
<article-title>Molecular and genetic determinants of the NMDA receptor for superior learning and memory functions</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.1371/journal.pone.0111865</pub-id>
</element-citation>
</ref>
<ref id="B146-ijms-21-01538">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta-Agarwal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jarome</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lubin</surname>
<given-names>F.D.</given-names>
</name>
</person-group>
<article-title>NMDA receptor- and ERK-dependent histone methylation changes in the lateral amygdala bidirectionally regulate fear memory formation</article-title>
<source/>Learn. Mem.
          <year>2014</year>
<volume>21</volume>
<fpage>351</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1101/lm.035105.114</pub-id>
<pub-id pub-id-type="pmid">24939839</pub-id>
</element-citation>
</ref>
<ref id="B147-ijms-21-01538">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holehonnur</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Phensy</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Milivojevic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vuong</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Daison</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Alex</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tiner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Kroener</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increasing the GluN2A/GluN2B ratio in neurons of the mouse basal and lateral amygdala inhibits the modification of an existing fear memory trace</article-title>
<source/>J. Neurosci.
          <year>2016</year>
<volume>36</volume>
<fpage>9490</fpage>
<lpage>9504</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1743-16.2016</pub-id>
<pub-id pub-id-type="pmid">27605622</pub-id>
</element-citation>
</ref>
<ref id="B148-ijms-21-01538">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Identifying the role of GluN2A in cerebral ischemia</article-title>
<source/>Front. Mol. Neurosci.
          <year>2017</year>
<pub-id pub-id-type="doi">10.3389/fnmol.2017.00012</pub-id>
</element-citation>
</ref>
<ref id="B149-ijms-21-01538">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyce-Rustay</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice</article-title>
<source/>Neuropsychopharmacology
          <year>2006</year>
<volume>31</volume>
<fpage>2405</fpage>
<lpage>2414</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1301039</pub-id>
<pub-id pub-id-type="pmid">16482087</pub-id>
</element-citation>
</ref>
<ref id="B150-ijms-21-01538">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taniguchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakazawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tanimura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kiyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tezuka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Watabe</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Katayama</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Izumi-Nakaseko</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Involvement of NMDAR2A tyrosine phosphorylation in depression-related behaviour</article-title>
<source/>EMBO J.
          <year>2009</year>
<volume>28</volume>
<fpage>3717</fpage>
<lpage>3729</lpage>
<pub-id pub-id-type="doi">10.1038/emboj.2009.300</pub-id>
<pub-id pub-id-type="pmid">19834457</pub-id>
</element-citation>
</ref>
<ref id="B151-ijms-21-01538">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>ITRAQ-based quantitative analysis of hippocampal postsynaptic density-associated proteins in a rat chronic mild stress model of depression</article-title>
<source/>Neuroscience
          <year>2015</year>
<volume>298</volume>
<fpage>220</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.04.006</pub-id>
<pub-id pub-id-type="pmid">25862978</pub-id>
</element-citation>
</ref>
<ref id="B152-ijms-21-01538">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feyissa</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Chandran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Karolewicz</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression</article-title>
<source/>Prog. Neuro-Psychopharmacology Biol. Psychiatry
          <year>2009</year>
<volume>33</volume>
<fpage>70</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2008.10.005</pub-id>
<pub-id pub-id-type="pmid">18992785</pub-id>
</element-citation>
</ref>
<ref id="B153-ijms-21-01538">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karolewicz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Szebeni</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gilmore</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>MacIag</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Ordway</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression</article-title>
<source/>Int. J. Neuropsychopharmacol.
          <year>2009</year>
<volume>12</volume>
<fpage>143</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="doi">10.1017/S1461145708008985</pub-id>
<pub-id pub-id-type="pmid">18570704</pub-id>
</element-citation>
</ref>
<ref id="B154-ijms-21-01538">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaut</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schlaepfer</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Wüllner</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Hurlemann</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Aberrant NMDA receptor DNA methylation detected by epigenome-wide analysis of hippocampus and prefrontal cortex in major depression</article-title>
<source/>Eur. Arch. Psychiatry Clin. Neurosci.
          <year>2015</year>
<volume>265</volume>
<fpage>331</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1007/s00406-014-0572-y</pub-id>
<pub-id pub-id-type="pmid">25571874</pub-id>
</element-citation>
</ref>
<ref id="B155-ijms-21-01538">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francija</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Petrovic</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Brkic</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Mitic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Radulovic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adzic</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Disruption of the NMDA receptor GluN2A subunit abolishes inflammation-induced depression</article-title>
<source/>Behav. Brain Res.
          <year>2019</year>
<volume>359</volume>
<fpage>550</fpage>
<lpage>559</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2018.10.011</pub-id>
<pub-id pub-id-type="pmid">30296532</pub-id>
</element-citation>
</ref>
<ref id="B156-ijms-21-01538">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Reduced levels of NR1 and NR2A with depression-like behavior in different brain regions in prenatally stressed juvenile offspring</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<pub-id pub-id-type="doi">10.1371/journal.pone.0081775</pub-id>
<pub-id pub-id-type="pmid">24278457</pub-id>
</element-citation>
</ref>
<ref id="B157-ijms-21-01538">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Involvement of NR1, NR2A different expression in brain regions in anxiety-like behavior of prenatally stressed offspring</article-title>
<source/>Behav. Brain Res.
          <year>2013</year>
<volume>257</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2013.08.044</pub-id>
<pub-id pub-id-type="pmid">24029697</pub-id>
</element-citation>
</ref>
<ref id="B158-ijms-21-01538">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itokawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yoshitsugu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Toyota</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Suga</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ohba</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kumakura</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia</article-title>
<source/>Pharmacogenetics
          <year>2003</year>
<volume>13</volume>
<fpage>271</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="doi">10.1097/00008571-200305000-00006</pub-id>
<pub-id pub-id-type="pmid">12724619</pub-id>
</element-citation>
</ref>
<ref id="B159-ijms-21-01538">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinacho</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Villalmanzo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Roca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iniesta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Monje</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Haro</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Meana</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Ferrer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: A pilot study of relationship to negative symptoms</article-title>
<source/>J. Psychiatr. Res.
          <year>2013</year>
<volume>47</volume>
<fpage>926</fpage>
<lpage>934</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2013.03.004</pub-id>
<pub-id pub-id-type="pmid">23540600</pub-id>
</element-citation>
</ref>
<ref id="B160-ijms-21-01538">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beneyto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder</article-title>
<source/>Neuropsychopharmacology
          <year>2008</year>
<volume>33</volume>
<fpage>2175</fpage>
<lpage>2186</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1301604</pub-id>
<pub-id pub-id-type="pmid">18033238</pub-id>
</element-citation>
</ref>
<ref id="B161-ijms-21-01538">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bitanihirwe</surname>
<given-names>B.K.Y.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>T.U.W.</given-names>
</name>
</person-group>
<article-title>Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia</article-title>
<source/>BMC Psychiatry
          <year>2009</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.1186/1471-244X-9-71</pub-id>
</element-citation>
</ref>
<ref id="B162-ijms-21-01538">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arning</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Valentin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saft</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Andrich</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Epplen</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>NR2A and NR2B receptor gene variations modify age at onset in Huntington disease</article-title>
<source/>Neurogenetics
          <year>2005</year>
<volume>6</volume>
<fpage>25</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1007/s10048-004-0198-8</pub-id>
<pub-id pub-id-type="pmid">15742215</pub-id>
</element-citation>
</ref>
<ref id="B163-ijms-21-01538">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luthi-Carter</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Apostol</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Dunah</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>DeJohn</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Farrell</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Bates</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Standaert</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>J.H.J.</given-names>
</name>
</person-group>
<article-title>Complex alteration of NMDA receptors in transgenic Huntington’s disease mouse brain: Analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation</article-title>
<source/>Neurobiol. Dis.
          <year>2003</year>
<volume>14</volume>
<fpage>624</fpage>
<lpage>636</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2003.08.024</pub-id>
<pub-id pub-id-type="pmid">14678777</pub-id>
</element-citation>
</ref>
<ref id="B164-ijms-21-01538">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6/2 mouse model of Huntington’s disease</article-title>
<source/>Dev. Neurosci.
          <year>2006</year>
<volume>28</volume>
<fpage>230</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1159/000091921</pub-id>
<pub-id pub-id-type="pmid">16679770</pub-id>
</element-citation>
</ref>
<ref id="B165-ijms-21-01538">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devinsky</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Vezzani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>O’rien</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Jette</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Scheffer</surname>
<given-names>I.E.</given-names>
</name>
<name>
<surname>de Curtis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Perucca</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Epilepsy</article-title>
<source/>Nat. Rev. Dis. Prim.
          <year>2018</year>
<volume>3</volume>
<fpage>18024</fpage>
</element-citation>
</ref>
<ref id="B166-ijms-21-01538">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemke</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Lal</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Reinthaler</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nothnagel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Geider</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Laube</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schwake</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Finsterwalder</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes</article-title>
<source/>Nat. Genet.
          <year>2013</year>
<volume>45</volume>
<fpage>1067</fpage>
<lpage>1072</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2728</pub-id>
<pub-id pub-id-type="pmid">23933819</pub-id>
</element-citation>
</ref>
<ref id="B167-ijms-21-01538">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lesca</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rudolf</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bruneau</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lozovaya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Labalme</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Boutry-Kryza</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Salmi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsintsadze</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Addis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Motte</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction</article-title>
<source/>Nat. Genet.
          <year>2013</year>
<volume>45</volume>
<fpage>1061</fpage>
<lpage>1066</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2726</pub-id>
<pub-id pub-id-type="pmid">23933820</pub-id>
</element-citation>
</ref>
<ref id="B168-ijms-21-01538">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvill</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Yendle</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Lozovaya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bruneau</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Burnashev</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Geraghty</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GRIN2A mutations cause epilepsy-aphasia spectrum disorders</article-title>
<source/>Nat. Genet.
          <year>2013</year>
<volume>45</volume>
<fpage>1073</fpage>
<lpage>1076</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2727</pub-id>
<pub-id pub-id-type="pmid">23933818</pub-id>
</element-citation>
</ref>
<ref id="B169-ijms-21-01538">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Ligt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Van Bon</surname>
<given-names>B.W.M.</given-names>
</name>
<name>
<surname>Kleefstra</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yntema</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Kroes</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vulto-van Silfhout</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Koolen</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>De Vries</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gilissen</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic exome sequencing in persons with severe intellectual disability</article-title>
<source/>N. Engl. J. Med.
          <year>2012</year>
<volume>367</volume>
<fpage>1921</fpage>
<lpage>1929</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1206524</pub-id>
<pub-id pub-id-type="pmid">23033978</pub-id>
</element-citation>
</ref>
<ref id="B170-ijms-21-01538">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogden</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Swanger</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>McDaniel</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>L.Z.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tankovic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kusumoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kosobucki</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Schulien</surname>
<given-names>A.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology</article-title>
<source/>PLoS Genet.
          <year>2017</year>
<volume>13</volume>
<elocation-id>e1006536</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1006536</pub-id>
<pub-id pub-id-type="pmid">28095420</pub-id>
</element-citation>
</ref>
<ref id="B171-ijms-21-01538">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierson</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Fuentes-Fajardo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Markello</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Golas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Simeonov</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Holloman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tankovic</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine</article-title>
<source/>Ann. Clin. Transl. Neurol.
          <year>2014</year>
<volume>1</volume>
<fpage>190</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1002/acn3.39</pub-id>
<pub-id pub-id-type="pmid">24839611</pub-id>
</element-citation>
</ref>
<ref id="B172-ijms-21-01538">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mark Pierson</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Markello</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Fajardo</surname>
<given-names>K.V.F.</given-names>
</name>
<name>
<surname>Holloman</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Golas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Boerkoel</surname>
<given-names>C.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy</article-title>
<source/>Nat. Commun.
          <year>2014</year>
<volume>5</volume>
<fpage>3251</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms4251</pub-id>
<pub-id pub-id-type="pmid">24504326</pub-id>
</element-citation>
</ref>
<ref id="B173-ijms-21-01538">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tankovic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Kusumoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Traynelis</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Functional evaluation of a de novo GRIN2A mutation identified in a patient with profound global developmental delay and refractory epilepsy</article-title>
<source/>Mol. Pharmacol.
          <year>2017</year>
<volume>91</volume>
<fpage>317</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1124/mol.116.106781</pub-id>
<pub-id pub-id-type="pmid">28126851</pub-id>
</element-citation>
</ref>
<ref id="B174-ijms-21-01538">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salter</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Kalia</surname>
<given-names>L.V.</given-names>
</name>
</person-group>
<article-title>SRC kinases: A hub for NMDA receptor regulation</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2004</year>
<volume>5</volume>
<fpage>317</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1038/nrn1368</pub-id>
<pub-id pub-id-type="pmid">15034556</pub-id>
</element-citation>
</ref>
<ref id="B175-ijms-21-01538">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sibarov</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Bruneau</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Antonov</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Szepetowski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Burnashev</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Giniatullin</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Functional properties of human NMDA receptors associated with epilepsy-related mutations of GluN2A subunit</article-title>
<source/>Front. Cell. Neurosci.
          <year>2017</year>
<fpage>155</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2017.00155</pub-id>
<pub-id pub-id-type="pmid">28611597</pub-id>
</element-citation>
</ref>
<ref id="B176-ijms-21-01538">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemke</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Geider</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Helbig</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Heyne</surname>
<given-names>H.O.</given-names>
</name>
<name>
<surname>Schütz</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hentschel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Courage</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Depienne</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nava</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy</article-title>
<source/>Neurology
          <year>2016</year>
<volume>86</volume>
<fpage>2171</fpage>
<lpage>2178</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000002740</pub-id>
<pub-id pub-id-type="pmid">27164704</pub-id>
</element-citation>
</ref>
<ref id="B177-ijms-21-01538">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanger</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Tankovic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Strong</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kusumoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains</article-title>
<source/>Am. J. Hum. Genet.
          <year>2016</year>
<volume>99</volume>
<fpage>1261</fpage>
<lpage>1280</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.10.002</pub-id>
<pub-id pub-id-type="pmid">27839871</pub-id>
</element-citation>
</ref>
<ref id="B178-ijms-21-01538">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>X.X.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Mutations of N-Methyl-D-Aspartate Receptor Subunits in Epilepsy</article-title>
<source/>Neurosci. Bull.
          <year>2018</year>
<volume>34</volume>
<fpage>549</fpage>
<lpage>565</lpage>
<pub-id pub-id-type="doi">10.1007/s12264-017-0191-5</pub-id>
<pub-id pub-id-type="pmid">29124671</pub-id>
</element-citation>
</ref>
<ref id="B179-ijms-21-01538">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Berkovic</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Cossette</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Delanty</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dlugos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Glauser</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in epileptic encephalopathies</article-title>
<source/>Nature
          <year>2013</year>
<volume>501</volume>
<fpage>217</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">23934111</pub-id>
</element-citation>
</ref>
<ref id="B180-ijms-21-01538">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Holyoak</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Arajs</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Hakimi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Markello</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Vilboux</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Fajardo</surname>
<given-names>K.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity</article-title>
<source/>Mol. Genet. Metab.
          <year>2014</year>
<volume>113</volume>
<fpage>161</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymgme.2014.04.001</pub-id>
<pub-id pub-id-type="pmid">24863970</pub-id>
</element-citation>
</ref>
<ref id="B181-ijms-21-01538">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gori</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Girardi</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>3-Mercaptopropionic acid-induced repetitive seizures increase glun2a expression in rat hippocampus: A potential neuroprotective role of cyclopentyladenosine</article-title>
<source/>Cell. Mol. Neurobiol.
          <year>2013</year>
<volume>33</volume>
<fpage>803</fpage>
<lpage>813</lpage>
<pub-id pub-id-type="doi">10.1007/s10571-013-9947-2</pub-id>
<pub-id pub-id-type="pmid">23748434</pub-id>
</element-citation>
</ref>
<ref id="B182-ijms-21-01538">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borbély</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dobó</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Czégé</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Molnár</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bakos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Szucs</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Vincze</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Világi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mihály</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Modification of ionotropic glutamate receptor-mediated processes in the rat hippocampus following repeated, brief seizures</article-title>
<source/>Neuroscience
          <year>2009</year>
<volume>159</volume>
<fpage>358</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.12.027</pub-id>
<pub-id pub-id-type="pmid">19154779</pub-id>
</element-citation>
</ref>
<ref id="B183-ijms-21-01538">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Z.Q.</given-names>
</name>
</person-group>
<article-title>Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis</article-title>
<source/>J. Neurosci.
          <year>2007</year>
<volume>27</volume>
<fpage>542</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3607-06.2007</pub-id>
<pub-id pub-id-type="pmid">17234586</pub-id>
</element-citation>
</ref>
<ref id="B184-ijms-21-01538">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GPR40 modulates epileptic seizure and NMDA receptor function</article-title>
<source/>Sci. Adv.
          <year>2018</year>
<volume>4</volume>
<fpage>eaau2357</fpage>
<pub-id pub-id-type="doi">10.1126/sciadv.aau2357</pub-id>
<pub-id pub-id-type="pmid">30345361</pub-id>
</element-citation>
</ref>
<ref id="B185-ijms-21-01538">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abegg</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Savic</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ehrengruber</surname>
<given-names>M.U.</given-names>
</name>
<name>
<surname>McKinney</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Gähwiler</surname>
<given-names>B.H.</given-names>
</name>
</person-group>
<article-title>Epileptiform activity in rat hippocampus strengthens excitatory synapses</article-title>
<source/>J. Physiol.
          <year>2004</year>
<volume>554</volume>
<fpage>439</fpage>
<lpage>448</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2003.052662</pub-id>
<pub-id pub-id-type="pmid">14594985</pub-id>
</element-citation>
</ref>
<ref id="B186-ijms-21-01538">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cain</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Hargreaves</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Boon</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dennison</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>An examination of the relations between hippocampal long-term potentiation, kindling, afterdischarge, and place learning in the water maze</article-title>
<source/>Hippocampus
          <year>1993</year>
<volume>3</volume>
<fpage>153</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1002/hipo.450030208</pub-id>
<pub-id pub-id-type="pmid">8353603</pub-id>
</element-citation>
</ref>
<ref id="B187-ijms-21-01538">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McNamara</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Kirkby</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>DePape</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Skelton</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Corcoran</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Differential effects of kindling and kindled seizures on place learning in the morris water maze</article-title>
<source/>Hippocampus
          <year>1993</year>
<volume>3</volume>
<fpage>149</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1002/hipo.450030207</pub-id>
</element-citation>
</ref>
<ref id="B188-ijms-21-01538">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rutten</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Van Albada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Silveira</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Cilio</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>G.L.</given-names>
</name>
</person-group>
<article-title>Memory impairment following status epilepticus in immature rats: Time-course and environmental effects</article-title>
<source/>Eur. J. Neurosci.
          <year>2002</year>
<volume>16</volume>
<fpage>501</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="doi">10.1046/j.1460-9568.2002.02103.x</pub-id>
<pub-id pub-id-type="pmid">12193194</pub-id>
</element-citation>
</ref>
<ref id="B189-ijms-21-01538">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guli</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tokay</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kirschstein</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Köhling</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Status Epilepticus Enhances Depotentiation after Fully Established LTP in an NMDAR-Dependent but GluN2B-Independent Manner</article-title>
<source/>Neural Plast.
          <year>2016</year>
<volume>2016</volume>
<pub-id pub-id-type="doi">10.1155/2016/6592038</pub-id>
</element-citation>
</ref>
<ref id="B190-ijms-21-01538">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Leary</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Castano</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Benke</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>Enhanced long term potentiation and decreased AMPA receptor desensitization in the acute period following a single kainate induced early life seizure</article-title>
<source/>Neurobiol. Dis.
          <year>2016</year>
<volume>87</volume>
<fpage>134</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2015.12.005</pub-id>
<pub-id pub-id-type="pmid">26706598</pub-id>
</element-citation>
</ref>
<ref id="B191-ijms-21-01538">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Müller</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tokay</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Porath</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Köhling</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kirschstein</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Enhanced NMDA receptor-dependent LTP in the epileptic CA1 area via upregulation of NR2B</article-title>
<source/>Neurobiol. Dis.
          <year>2013</year>
<volume>54</volume>
<fpage>183</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2012.12.011</pub-id>
<pub-id pub-id-type="pmid">23313317</pub-id>
</element-citation>
</ref>
<ref id="B192-ijms-21-01538">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kryukov</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Magazanik</surname>
<given-names>L.G.</given-names>
</name>
<name>
<surname>Zaitsev</surname>
<given-names>A.V.</given-names>
</name>
</person-group>
<article-title>Status epilepticus alters hippocampal long-term synaptic potentiation in a rat lithium-pilocarpine model</article-title>
<source/>Neuroreport
          <year>2016</year>
<volume>27</volume>
<fpage>1191</fpage>
<lpage>1195</lpage>
<pub-id pub-id-type="doi">10.1097/WNR.0000000000000656</pub-id>
<pub-id pub-id-type="pmid">27495218</pub-id>
</element-citation>
</ref>
<ref id="B193-ijms-21-01538">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Shatskikh</surname>
<given-names>T.N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>G.L.</given-names>
</name>
</person-group>
<article-title>Impaired single cell firing and long-term potentiation parallels memory impairment following recurrent seizures</article-title>
<source/>Eur. J. Neurosci.
          <year>2007</year>
<volume>25</volume>
<fpage>3667</fpage>
<lpage>3677</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05598.x</pub-id>
<pub-id pub-id-type="pmid">17610586</pub-id>
</element-citation>
</ref>
<ref id="B194-ijms-21-01538">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suárez</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Cid</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gal</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Inostroza</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brotons-Mas</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Gómez-Domínguez</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>de la Prida</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Solís</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Systemic Injection of Kainic Acid Differently Affects LTP Magnitude Depending on its Epileptogenic Efficiency</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e48128</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0048128</pub-id>
<pub-id pub-id-type="pmid">23118939</pub-id>
</element-citation>
</ref>
<ref id="B195-ijms-21-01538">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanson</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Elstrott</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saillet</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Simms</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>G.Q.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease Models</article-title>
<source/>Cell Rep.
          <year>2020</year>
<volume>30</volume>
<fpage>381</fpage>
<lpage>396.e4</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2019.12.030</pub-id>
<pub-id pub-id-type="pmid">31940483</pub-id>
</element-citation>
</ref>
<ref id="B196-ijms-21-01538">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zukin</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders</article-title>
<source/>Neuron
          <year>2019</year>
<volume>101</volume>
<fpage>1070</fpage>
<lpage>1088</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2019.02.041</pub-id>
<pub-id pub-id-type="pmid">30897358</pub-id>
</element-citation>
</ref>
<ref id="B197-ijms-21-01538">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhat</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Acharya</surname>
<given-names>U.R.</given-names>
</name>
<name>
<surname>Adeli</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bairy</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Adeli</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Autism: Cause factors, early diagnosis and therapies</article-title>
<source/>Rev. Neurosci.
          <year>2014</year>
<volume>25</volume>
<fpage>841</fpage>
<lpage>850</lpage>
<pub-id pub-id-type="doi">10.1515/revneuro-2014-0056</pub-id>
<pub-id pub-id-type="pmid">25222596</pub-id>
</element-citation>
</ref>
<ref id="B198-ijms-21-01538">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volkmar</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>McPartland</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>From Kanner to DSM-5: Autism as an Evolving Diagnostic Concept</article-title>
<source/>Annu. Rev. Clin. Psychol.
          <year>2014</year>
<volume>10</volume>
<fpage>193</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-clinpsy-032813-153710</pub-id>
<pub-id pub-id-type="pmid">24329180</pub-id>
</element-citation>
</ref>
<ref id="B199-ijms-21-01538">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B.N.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Paek</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>A short review on the current understanding of autism spectrum disorders</article-title>
<source/>Exp. Neurobiol.
          <year>2016</year>
<volume>25</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.5607/en.2016.25.1.1</pub-id>
<pub-id pub-id-type="pmid">26924928</pub-id>
</element-citation>
</ref>
<ref id="B200-ijms-21-01538">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waye</surname>
<given-names>M.M.Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Genetics and epigenetics of autism: A Review</article-title>
<source/>Psychiatry Clin. Neurosci.
          <year>2018</year>
<volume>72</volume>
<fpage>228</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1111/pcn.12606</pub-id>
<pub-id pub-id-type="pmid">28941239</pub-id>
</element-citation>
</ref>
<ref id="B201-ijms-21-01538">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tassone</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Neri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hagerman</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Fragile X syndrome: Causes, diagnosis, mechanisms, and therapeutics</article-title>
<source/>J. Clin. Invest.
          <year>2012</year>
<volume>122</volume>
<fpage>4314</fpage>
<lpage>4322</lpage>
<pub-id pub-id-type="doi">10.1172/JCI63141</pub-id>
<pub-id pub-id-type="pmid">23202739</pub-id>
</element-citation>
</ref>
<ref id="B202-ijms-21-01538">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bassell</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>S.T.</given-names>
</name>
</person-group>
<article-title>Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function</article-title>
<source/>Neuron
          <year>2008</year>
<volume>60</volume>
<fpage>201</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.004</pub-id>
<pub-id pub-id-type="pmid">18957214</pub-id>
</element-citation>
</ref>
<ref id="B203-ijms-21-01538">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rubeis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bagni</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability</article-title>
<source/>Mol. Cell. Neurosci.
          <year>2010</year>
<volume>43</volume>
<fpage>43</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2009.09.013</pub-id>
<pub-id pub-id-type="pmid">19837168</pub-id>
</element-citation>
</ref>
<ref id="B204-ijms-21-01538">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pasciuto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bagni</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>SnapShot: FMRP mRNA targets and diseases</article-title>
<source/>Cell
          <year>2014</year>
<volume>158</volume>
<fpage>1446</fpage>
<lpage>1446.e1</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.08.035</pub-id>
<pub-id pub-id-type="pmid">25215498</pub-id>
</element-citation>
</ref>
<ref id="B205-ijms-21-01538">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zoghbi</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities</article-title>
<source/>Cold Spring Harb. Perspect. Biol.
          <year>2012</year>
<volume>4</volume>
<fpage>a009886</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a009886</pub-id>
<pub-id pub-id-type="pmid">22258914</pub-id>
</element-citation>
</ref>
<ref id="B206-ijms-21-01538">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawicka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pyronneau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>M.V.L.</given-names>
</name>
<name>
<surname>Zukin</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Elevated erk/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in Fragile X mice</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<fpage>E6290</fpage>
<lpage>E6297</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1610812113</pub-id>
<pub-id pub-id-type="pmid">27663742</pub-id>
</element-citation>
</ref>
<ref id="B207-ijms-21-01538">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Snape</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Klann</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Castellani</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Casadesus</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome</article-title>
<source/>J. Neurochem.
          <year>2012</year>
<volume>121</volume>
<fpage>672</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07722.x</pub-id>
<pub-id pub-id-type="pmid">22393900</pub-id>
</element-citation>
</ref>
<ref id="B208-ijms-21-01538">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pasciuto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wahle</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>D’Andrea</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pacini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jacquemont</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tassone</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Balschun</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dotti</surname>
<given-names>C.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome</article-title>
<source/>Neuron
          <year>2015</year>
<volume>87</volume>
<fpage>382</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2015.06.032</pub-id>
<pub-id pub-id-type="pmid">26182420</pub-id>
</element-citation>
</ref>
<ref id="B209-ijms-21-01538">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lauterborn</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Rex</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Kramár</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Pandyarajan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gall</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome</article-title>
<source/>J. Neurosci.
          <year>2007</year>
<volume>27</volume>
<fpage>10685</fpage>
<lpage>10694</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2624-07.2007</pub-id>
<pub-id pub-id-type="pmid">17913902</pub-id>
</element-citation>
</ref>
<ref id="B210-ijms-21-01538">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>W.P.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.X.</given-names>
</name>
<name>
<surname>Rowson-Baldwin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>L.Y.</given-names>
</name>
</person-group>
<article-title>Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein</article-title>
<source/>Neuron
          <year>2011</year>
<volume>72</volume>
<fpage>630</fpage>
<lpage>642</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.033</pub-id>
<pub-id pub-id-type="pmid">22099464</pub-id>
</element-citation>
</ref>
<ref id="B211-ijms-21-01538">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paradee</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Melikian</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Kenneson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Conn</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>S.T.</given-names>
</name>
</person-group>
<article-title>Fragile X mouse: Strain effects of knockout phenotype and evidence suggesting deficient amygdala function</article-title>
<source/>Neuroscience
          <year>1999</year>
<volume>94</volume>
<fpage>185</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(99)00285-7</pub-id>
<pub-id pub-id-type="pmid">10613508</pub-id>
</element-citation>
</ref>
<ref id="B212-ijms-21-01538">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Toyoda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome</article-title>
<source/>J. Neurosci.
          <year>2005</year>
<volume>25</volume>
<fpage>7385</fpage>
<lpage>7392</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1520-05.2005</pub-id>
<pub-id pub-id-type="pmid">16093389</pub-id>
</element-citation>
</ref>
<ref id="B213-ijms-21-01538">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desai</surname>
<given-names>N.S.</given-names>
</name>
<name>
<surname>Casimiro</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Vanderklish</surname>
<given-names>P.W.</given-names>
</name>
</person-group>
<article-title>Early postnatal plasticity in neocortex of Fmr1 knockout mice</article-title>
<source/>J. Neurophysiol.
          <year>2006</year>
<volume>96</volume>
<fpage>1734</fpage>
<lpage>1745</lpage>
<pub-id pub-id-type="doi">10.1152/jn.00221.2006</pub-id>
<pub-id pub-id-type="pmid">16823030</pub-id>
</element-citation>
</ref>
<ref id="B214-ijms-21-01538">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meredith</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Holmgren</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Weidum</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Burnashev</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mansvelder</surname>
<given-names>H.D.</given-names>
</name>
</person-group>
<article-title>Increased Threshold for Spike-Timing-Dependent Plasticity Is Caused by Unreliable Calcium Signaling in Mice Lacking Fragile X Gene Fmr1</article-title>
<source/>Neuron
          <year>2007</year>
<volume>54</volume>
<fpage>627</fpage>
<lpage>638</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.04.028</pub-id>
<pub-id pub-id-type="pmid">17521574</pub-id>
</element-citation>
</ref>
<ref id="B215-ijms-21-01538">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mercaldo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice</article-title>
<source/>J. Neurochem.
          <year>2009</year>
<volume>111</volume>
<fpage>635</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06314.x</pub-id>
<pub-id pub-id-type="pmid">19659572</pub-id>
</element-citation>
</ref>
<ref id="B216-ijms-21-01538">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundbye</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Toft</surname>
<given-names>A.K.H.</given-names>
</name>
<name>
<surname>Banke</surname>
<given-names>T.G.</given-names>
</name>
</person-group>
<article-title>Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1−/y mouse model</article-title>
<source/>J. Physiol.
          <year>2018</year>
<volume>596</volume>
<fpage>5017</fpage>
<lpage>5031</lpage>
<pub-id pub-id-type="doi">10.1113/JP276304</pub-id>
<pub-id pub-id-type="pmid">30132892</pub-id>
</element-citation>
</ref>
<ref id="B217-ijms-21-01538">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yun</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Trommer</surname>
<given-names>B.L.</given-names>
</name>
</person-group>
<article-title>Fragile X mice: Reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus</article-title>
<source/>J. Neurosci. Res.
          <year>2011</year>
<volume>89</volume>
<fpage>176</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.22546</pub-id>
<pub-id pub-id-type="pmid">21162125</pub-id>
</element-citation>
</ref>
<ref id="B218-ijms-21-01538">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huber</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Altered synaptic plasticity in a mouse model of fragile X mental retardation</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2002</year>
<volume>99</volume>
<fpage>7746</fpage>
<lpage>7750</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.122205699</pub-id>
<pub-id pub-id-type="pmid">12032354</pub-id>
</element-citation>
</ref>
<ref id="B219-ijms-21-01538">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bear</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>S.T.</given-names>
</name>
</person-group>
<article-title>The mGluR theory of fragile X mental retardation</article-title>
<source/>Trends Neurosci.
          <year>2004</year>
<volume>27</volume>
<fpage>370</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2004.04.009</pub-id>
<pub-id pub-id-type="pmid">15219735</pub-id>
</element-citation>
</ref>
<ref id="B220-ijms-21-01538">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eadie</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Cushman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kannangara</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Fanselow</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Christie</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>NMDA receptor hypofunction in the dentate gyrus and impaired context discrimination in adult Fmr1 knockout mice</article-title>
<source/>Hippocampus
          <year>2012</year>
<volume>22</volume>
<fpage>241</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1002/hipo.20890</pub-id>
<pub-id pub-id-type="pmid">21049485</pub-id>
</element-citation>
</ref>
<ref id="B221-ijms-21-01538">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McHugh</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Balthasar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Coppari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Elmquist</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Lowell</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Fanselow</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Tonegawa</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network</article-title>
<source/>Science (80-. )
          <year>2007</year>
<volume>317</volume>
<fpage>94</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1126/science.1140263</pub-id>
</element-citation>
</ref>
<ref id="B222-ijms-21-01538">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eadie</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.N.</given-names>
</name>
<name>
<surname>Boehme</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gil-Mohapel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kainer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Christie</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>Fmr1 knockout mice show reduced anxiety and alterations in neurogenesis that are specific to the ventral dentate gyrus</article-title>
<source/>Neurobiol. Dis.
          <year>2009</year>
<volume>36</volume>
<fpage>361</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2009.08.001</pub-id>
<pub-id pub-id-type="pmid">19666116</pub-id>
</element-citation>
</ref>
<ref id="B223-ijms-21-01538">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Hooge</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nagels</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Franck</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bakker</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Reyniers</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Storm</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kooy</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Oostra</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>De Deyn</surname>
<given-names>P.P.</given-names>
</name>
</person-group>
<article-title>Mildly impaired water maze performance in male Fmr1 knockout mice</article-title>
<source/>Neuroscience
          <year>1997</year>
<volume>76</volume>
<fpage>367</fpage>
<lpage>376</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(96)00224-2</pub-id>
<pub-id pub-id-type="pmid">9015322</pub-id>
</element-citation>
</ref>
<ref id="B224-ijms-21-01538">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dölen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Osterweil</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>B.S.S.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Auerbach</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Chattarji</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Correction of Fragile X Syndrome in Mice</article-title>
<source/>Neuron
          <year>2007</year>
<volume>56</volume>
<fpage>955</fpage>
<lpage>962</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.001</pub-id>
<pub-id pub-id-type="pmid">18093519</pub-id>
</element-citation>
</ref>
<ref id="B225-ijms-21-01538">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dalton</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Floresco</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>A.G.</given-names>
</name>
</person-group>
<article-title>Disruption of AMPA receptor endocytosis impairs the extinction, but not acquisition of learned fear</article-title>
<source/>Neuropsychopharmacology
          <year>2008</year>
<volume>33</volume>
<fpage>2416</fpage>
<lpage>2426</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1301642</pub-id>
<pub-id pub-id-type="pmid">18046303</pub-id>
</element-citation>
</ref>
<ref id="B226-ijms-21-01538">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Integrated Transcriptome Analyses Revealed Key Target Genes in Mouse Models of Autism</article-title>
<source/>Autism Res.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1002/aur.2240</pub-id>
</element-citation>
</ref>
<ref id="B227-ijms-21-01538">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bellone</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Modulation of the glutamatergic transmission by Dopamine: A focus on Parkinson, Huntington and Addiction diseases</article-title>
<source/>Front. Cell. Neurosci.
          <year>2015</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00025</pub-id>
</element-citation>
</ref>
<ref id="B228-ijms-21-01538">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calabresi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Picconi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tozzi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Di Filippo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Dopamine-mediated regulation of corticostriatal synaptic plasticity</article-title>
<source/>Trends Neurosci.
          <year>2007</year>
<volume>30</volume>
<fpage>211</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2007.03.001</pub-id>
<pub-id pub-id-type="pmid">17367873</pub-id>
</element-citation>
</ref>
<ref id="B229-ijms-21-01538">
<label>229.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunah</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yasuda</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Kameyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Huganir</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Standaert</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson’s disease</article-title>
<source/>Mol. Pharmacol.
          <year>2000</year>
<volume>57</volume>
<fpage>342</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="pmid">10648644</pub-id>
</element-citation>
</ref>
<ref id="B230-ijms-21-01538">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Picconi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ghiglieri</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Polli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bagetta</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cattabeni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Di Luca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia</article-title>
<source/>J. Neurosci.
          <year>2006</year>
<volume>26</volume>
<fpage>2914</fpage>
<lpage>2922</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5326-05.2006</pub-id>
<pub-id pub-id-type="pmid">16540568</pub-id>
</element-citation>
</ref>
<ref id="B231-ijms-21-01538">
<label>231.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paillé</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Picconi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bagetta</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ghiglieri</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sgobio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Di Filippo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Viscomi</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Giampà</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fusco</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition</article-title>
<source/>J. Neurosci.
          <year>2010</year>
<volume>30</volume>
<fpage>14182</fpage>
<lpage>14193</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2149-10.2010</pub-id>
<pub-id pub-id-type="pmid">20962239</pub-id>
</element-citation>
</ref>
<ref id="B232-ijms-21-01538">
<label>232.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mellone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stanic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Iglesias</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zianni</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Longhi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prigent</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Picconi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>E.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: From experimental models to patients</article-title>
<source/>Front. Cell. Neurosci.
          <year>2015</year>
<volume>9</volume>
<fpage>245</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00245</pub-id>
<pub-id pub-id-type="pmid">26217176</pub-id>
</element-citation>
</ref>
<ref id="B233-ijms-21-01538">
<label>233.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durante</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>De Iure</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Loffredo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Vaikath</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>De Risi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Paciotti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Quiroga-Varela</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chiasserini</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mellone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mazzocchetti</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration</article-title>
<source/>Brain
          <year>2019</year>
<volume>142</volume>
<fpage>1365</fpage>
<lpage>1385</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awz065</pub-id>
<pub-id pub-id-type="pmid">30927362</pub-id>
</element-citation>
</ref>
<ref id="B234-ijms-21-01538">
<label>234.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diógenes</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Rombo</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Vicente Miranda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Maiolino</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guerreiro</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Näsström</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Franquelim</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>L.M.A.</given-names>
</name>
<name>
<surname>Castanho</surname>
<given-names>M.A.R.B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<fpage>11750</fpage>
<lpage>11762</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0234-12.2012</pub-id>
<pub-id pub-id-type="pmid">22915117</pub-id>
</element-citation>
</ref>
<ref id="B235-ijms-21-01538">
<label>235.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bastide</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Meissner</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Picconi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fasano</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fernagut</surname>
<given-names>P.O.</given-names>
</name>
<name>
<surname>Feyder</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Francardo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Alcacer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Brambilla</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson’s disease</article-title>
<source/>Prog. Neurobiol.
          <year>2015</year>
<volume>132</volume>
<fpage>96</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.07.002</pub-id>
<pub-id pub-id-type="pmid">26209473</pub-id>
</element-citation>
</ref>
<ref id="B236-ijms-21-01538">
<label>236.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Lloret</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rascol</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia</article-title>
<source/>J. Neural Transm.
          <year>2018</year>
<volume>125</volume>
<fpage>1237</fpage>
<lpage>1250</lpage>
<pub-id pub-id-type="doi">10.1007/s00702-018-1869-1</pub-id>
<pub-id pub-id-type="pmid">29511826</pub-id>
</element-citation>
</ref>
<ref id="B237-ijms-21-01538">
<label>237.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Picconi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Centonze</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Håkansson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Greengard</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fisone</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cenci</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia</article-title>
<source/>Nat. Neurosci.
          <year>2003</year>
<volume>6</volume>
<fpage>501</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1038/nn1040</pub-id>
<pub-id pub-id-type="pmid">12665799</pub-id>
</element-citation>
</ref>
<ref id="B238-ijms-21-01538">
<label>238.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prescott</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Dostrovsky</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Hodaie</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lozano</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Hutchison</surname>
<given-names>W.D.</given-names>
</name>
</person-group>
<article-title>Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia</article-title>
<source/>Neurobiol. Dis.
          <year>2014</year>
<volume>71</volume>
<fpage>24</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2014.08.002</pub-id>
<pub-id pub-id-type="pmid">25116960</pub-id>
</element-citation>
</ref>
<ref id="B239-ijms-21-01538">
<label>239.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallett</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Dunah</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Ravenscroft</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bezard</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Crossman</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Brotchie</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Standaert</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson’s disease</article-title>
<source/>Neuropharmacology
          <year>2005</year>
<volume>48</volume>
<fpage>503</fpage>
<lpage>516</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.11.008</pub-id>
<pub-id pub-id-type="pmid">15755478</pub-id>
</element-citation>
</ref>
<ref id="B240-ijms-21-01538">
<label>240.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sgobio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pendolino</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Di Luca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Picconi</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias</article-title>
<source/>Neurobiol. Aging
          <year>2012</year>
<volume>33</volume>
<fpage>2138</fpage>
<lpage>2144</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.06.019</pub-id>
<pub-id pub-id-type="pmid">21821315</pub-id>
</element-citation>
</ref>
<ref id="B241-ijms-21-01538">
<label>241.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mellone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Napolitano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Racca</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zianni</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Minocci</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ghiglieri</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Thiolat</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Longhi</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias</article-title>
<source/>Neurobiol. Dis.
          <year>2017</year>
<volume>108</volume>
<fpage>54</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2017.08.001</pub-id>
<pub-id pub-id-type="pmid">28823933</pub-id>
</element-citation>
</ref>
<ref id="B242-ijms-21-01538">
<label>242.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quartarone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hallett</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Emerging concepts in the physiological basis of dystonia</article-title>
<source/>Mov. Disord.
          <year>2013</year>
<volume>28</volume>
<fpage>958</fpage>
<lpage>967</lpage>
<pub-id pub-id-type="doi">10.1002/mds.25532</pub-id>
<pub-id pub-id-type="pmid">23893452</pub-id>
</element-citation>
</ref>
<ref id="B243-ijms-21-01538">
<label>243.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quartarone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rizzo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Terranova</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Morgante</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Girlanda</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bhatia</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Rothwell</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia</article-title>
<source/>Brain
          <year>2009</year>
<volume>132</volume>
<fpage>2871</fpage>
<lpage>2877</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awp213</pub-id>
<pub-id pub-id-type="pmid">19690095</pub-id>
</element-citation>
</ref>
<ref id="B244-ijms-21-01538">
<label>244.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maltese</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stanic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tassone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sciamanna</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ponterio</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vanni</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Martella</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Imbriani</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bonsi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mercuri</surname>
<given-names>N.B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum</article-title>
<source/>Elife
          <year>2018</year>
<volume>7</volume>
<fpage>e33331</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.33331</pub-id>
<pub-id pub-id-type="pmid">29504938</pub-id>
</element-citation>
</ref>
<ref id="B245-ijms-21-01538">
<label>245.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamenetz</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tomita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Seabrook</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Borchelt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Iwatsubo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sisodia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>APP Processing and Synaptic Function</article-title>
<source/>Neuron
          <year>2003</year>
<volume>37</volume>
<fpage>925</fpage>
<lpage>937</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(03)00124-7</pub-id>
<pub-id pub-id-type="pmid">12670422</pub-id>
</element-citation>
</ref>
<ref id="B246-ijms-21-01538">
<label>246.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsieh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Boehm</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Iwatsubo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tomita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sisodia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss</article-title>
<source/>Neuron
          <year>2006</year>
<volume>52</volume>
<fpage>831</fpage>
<lpage>843</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2006.10.035</pub-id>
<pub-id pub-id-type="pmid">17145504</pub-id>
</element-citation>
</ref>
<ref id="B247-ijms-21-01538">
<label>247.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Anwyl</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Djamgoz</surname>
<given-names>M.B.A.</given-names>
</name>
<name>
<surname>Rowan</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Use-dependent effects of amyloidogenic fragments of β-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo</article-title>
<source/>J. Neurosci.
          <year>2001</year>
<volume>21</volume>
<fpage>1327</fpage>
<lpage>1333</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-04-01327.2001</pub-id>
<pub-id pub-id-type="pmid">11160403</pub-id>
</element-citation>
</ref>
<ref id="B248-ijms-21-01538">
<label>248.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shepardson</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake</article-title>
<source/>Neuron
          <year>2009</year>
<volume>62</volume>
<fpage>788</fpage>
<lpage>801</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.05.012</pub-id>
<pub-id pub-id-type="pmid">19555648</pub-id>
</element-citation>
</ref>
<ref id="B249-ijms-21-01538">
<label>249.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>N.W.</given-names>
</name>
<name>
<surname>Klyubin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Anwy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rowan</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>GluN2B subunit-containing NMDA receptor antagonists prevent Aβ-mediated synaptic plasticity disruption in vivo</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>20504</fpage>
<lpage>20509</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0908083106</pub-id>
<pub-id pub-id-type="pmid">19918059</pub-id>
</element-citation>
</ref>
<ref id="B250-ijms-21-01538">
<label>250.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koeglsperger</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shepardson</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Soluble a β oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors</article-title>
<source/>J. Neurosci.
          <year>2011</year>
<volume>31</volume>
<fpage>6627</fpage>
<lpage>6638</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0203-11.2011</pub-id>
<pub-id pub-id-type="pmid">21543591</pub-id>
</element-citation>
</ref>
<ref id="B251-ijms-21-01538">
<label>251.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rönicke</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mikhaylova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rönicke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meinhardt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schröder</surname>
<given-names>U.H.</given-names>
</name>
<name>
<surname>Fändrich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Reiser</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kreutz</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Reymann</surname>
<given-names>K.G.</given-names>
</name>
</person-group>
<article-title>Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors</article-title>
<source/>Neurobiol. Aging
          <year>2011</year>
<volume>32</volume>
<fpage>2219</fpage>
<lpage>2228</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2010.01.011</pub-id>
<pub-id pub-id-type="pmid">20133015</pub-id>
</element-citation>
</ref>
<ref id="B252-ijms-21-01538">
<label>252.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Texidó</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Martín-Satué</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alberdi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Solsona</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Matute</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Amyloid β peptide oligomers directly activate NMDA receptors</article-title>
<source/>Cell Calcium
          <year>2011</year>
<volume>49</volume>
<fpage>184</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1016/j.ceca.2011.02.001</pub-id>
<pub-id pub-id-type="pmid">21349580</pub-id>
</element-citation>
</ref>
<ref id="B253-ijms-21-01538">
<label>253.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aoki</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nedelescu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Increased levels of NMDA receptor NR2A subunits at pre- and postsynaptic sites of the hippocampal CA1: An early response to conditional double knockout of presenilin 1 and 2</article-title>
<source/>J. Comp. Neurol.
          <year>2009</year>
<volume>517</volume>
<fpage>512</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="doi">10.1002/cne.22151</pub-id>
<pub-id pub-id-type="pmid">19795494</pub-id>
</element-citation>
</ref>
<ref id="B254-ijms-21-01538">
<label>254.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kessels</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Nabavi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Metabotropic NMDA receptor function is required for β-amyloid-induced synaptic depression</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>4033</fpage>
<lpage>4038</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1219605110</pub-id>
<pub-id pub-id-type="pmid">23431156</pub-id>
</element-citation>
</ref>
<ref id="B255-ijms-21-01538">
<label>255.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tak</surname>
<given-names>P.W.</given-names>
</name>
<name>
<surname>Aarts</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rooyakkers</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ted</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tymianski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>A.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo</article-title>
<source/>J. Neurosci.
          <year>2007</year>
<volume>27</volume>
<fpage>2846</fpage>
<lpage>2857</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0116-07.2007</pub-id>
<pub-id pub-id-type="pmid">17360906</pub-id>
</element-citation>
</ref>
<ref id="B256-ijms-21-01538">
<label>256.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marcello</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Musardo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vandermeulen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pelucchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gardoni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Santo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Antonucci</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Di Luca</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena</article-title>
<source/>Mol. Neurobiol.
          <year>2019</year>
<volume>56</volume>
<fpage>7136</fpage>
<lpage>7143</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-019-1583-5</pub-id>
<pub-id pub-id-type="pmid">30989630</pub-id>
</element-citation>
</ref>
<ref id="B257-ijms-21-01538">
<label>257.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tackenberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Grinschgl</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Trutzel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Santuccione</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Konietzko</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Grimm</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nitsch</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss</article-title>
<source/>Cell Death Dis.
          <year>2013</year>
<volume>4</volume>
<fpage>e608</fpage>
<pub-id pub-id-type="doi">10.1038/cddis.2013.129</pub-id>
<pub-id pub-id-type="pmid">23618906</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-21-01538-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Graphic representation of GluN2A interactors at C-terminal domain (CTD). (<bold>A</bold>) In basal condition, GluN2A CTD binds RNF10 at aa991-1049; BRAG2 at aa1078-1117; Cdk5 at aa1218-1246; CaMKII at aa1389-1464; Scribble1 at 1458-1464; and PSD scaffolding proteins such as PSD-93, PSD-95, SAP102, and SAP97 at aa1461-1464. (<bold>B</bold>) Upon LTP induction, phosphorylation of RNF10 triggers RNF10 detachment and its nuclear translocation. Simultaneously, CaM binds to aa875-1029 of GluN2A. BRAG2 exchanges GDP with GTP to Arf6-GTPase, which is involved is vesicles recycle at the postsynapse, also with Scribble1. Rph3A interaction with GluN2A at aa1349-1389 increases. CaMKII is disinhibited and is recruited at the postsynapse. Ras-ERK downstream cascade is initiated.</p>
</caption>
<graphic xlink:href="ijms-21-01538-g001"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>